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Zusammenfassung  
1 Zusammenfassung 
GABAA-Rezeptoren sind pentamere Liganden-gesteuerte Ionenkanäle, die die tonisch-
inhibitorische Transmission im Gehirn vermitteln. Neben der Bindungstelle für den 
Neurotransmitter GABA verfügen GABAA-Rezeptoren über verschiedene distinkte 
allosterische Bindungsstellen, welche u. a. die klinisch relevanten Wirkungen von 
Benzodiazepinen, Barbituraten und einigen Anästhetika mediieren. GABAA-Rezeptoren 
treten in einer Vielzahl von Subtypen auf. Die häufigsten und klinisch relevanten 
Rezeptorsubtypen setzen sich aus zwei α- (α1, 2, 3 oder 5), zwei β (β1, 2 oder 3) und 
der γ2-Untereinheit zusammen. Die einzelnen Rezeptorsubtypen weisen 
unterschiedliche temporale und regionale Expressionsmuster auf, was auf spezialisierte 
physiologische Funktionen hinweist. Die vorliegende Studie konzentrierte sich auf die 
α5-GABAA-Rezeptoren, die in vergleichsweise hoher Konzentration in den 
Pyramidenzellen des Hippocampus exprimiert werden. Sie sind vor allem in 
extrasynaptischen somato-dendritischen Bereichen lokalisiert und spielen eine wichtige 
Rolle in der Regulation von Lern- und Gedächtnisprozessen. 
Unerwarteter Weise führte eine Punkmutation in der Benzodiazepin-Bindungsstelle der 
α5-Untereinheit (H105R), die in das Mausgenom eingeführt wurde um eine 
Unempfindlichkeit der α5-GABAA-Rezeptoren gegenüber Diazepam zu erreichen, zu 
einer verringerten Expression der α5-Untereinheit im Hippocampus. Diese Reduktion 
der α5-Untereinheit korrelierte mit einer verstärkten Angstkonditionierung, die eine 
Hippocampus-abhängige Form des Assoziantions-lernens darstellt (Crestani et al. 
2002). Da die Ursache für Reduktion der α5-Untereinheit im Hippocampus unbekannt 
war, wurde in der vorliegenden Studie untersucht, ob die H105R-Mutation das 
Targeting und/oder die Assemblierung der α5-GABAA-Rezeptoren beeinflusst. Darüber 
hinaus wurde analysiert, ob die verminderte Expression der α5-Untereinheit einen 
Einfluss auf die Expression und/oder die Aktivität von Signalproteinen hat, die eine 
wichtige Funktion bei Lern- und Gedächtnisprozessen ausüben. 
Eine Western-Blot-Analyse zeigte, dass die Expression des α5-Untereinheitenproteins 
in α5(H105R)-Mäusen nur moderat (~23%) reduziert ist. Allerdings wiesen 
Radioligand-Bindungsstudien auf eine starke Reduktion (~50-70%) der α5-GABAA 
Rezeptoren hin. Immunhistochemische sowie ELISA Experimente ergaben, dass sowohl 
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CREB eine adaptive Kompensation einer chronisch erhöhten NMDA Rezeptor Aktivität 
darstellen.
 Summary 
 
2 Summary 
GABAA receptors are pentameric ligand-gated ion channels that are major mediators of 
the inhibitory tone throughout the central nervous system. They are the site of action of 
many clinically important drugs, including benzodiazepines, barbiturates and some 
general anesthetics. GABAA receptors exhibit an enormous structural heterogeneity 
based on the combinatorial assembly of a variety of distinct subunits. The major and 
clinically relevant GABAA receptor subtypes are composed of α1,2,3,5, β1-3 and γ2 
subunits. These receptor subtypes display distinct temporal and spatial expression 
patterns, indicating different specialized physiological roles. In this study we focused on 
α5-GABAA receptors, which are highly expressed in hippocampal pyramidal cells. 
They are predominantly localized extrasynaptically in somato-dendritic membranes and 
play an important role in regulating learning and memory.  
Introduction of the H105R point mutation into the α5 subunit, to render α5-containing 
receptors insensitive to the clinically important benzodiazepine site drug diazepam, 
unexpectedly resulted in a reduced level of α5 subunit protein in the hippocampus. This 
reduction in α5 subunit protein was associated with facilitated trace fear conditioning, a 
hippocampus dependent form of associative learning (Crestani et al. 2002). Since the 
cause for the reduction of α5-subunit protein is unknown, we aimed in the present study 
at exploring whether the α5(H105R) mutation affects the targeting and/or the assembly 
of α5-GABAA receptors. In addition, we analyzed the effect of diminished hippocampal 
α5-GABAA receptors on the activity of downstream signaling proteins important for 
learning and memory.   
Western blot analysis revealed that the level of the α5 subunit protein is only 
moderately reduced (~23%) in α5(H105R) mice. However, when the level of receptors 
was determined by radioligand binding, α5-GABAA receptors were found to be severely 
decreased (~50-70%) not only in the hippocampus but in all brain areas expressing α5-
GABAA receptors. Immunocytochemical and ELISA experiments on α5-GABAA 
receptors expressed in HEK293 cells demonstrated similar expression levels and cell 
surface targeting irrespective of whether wild type or mutant α5-GABAA receptors were 
used. Likewise, expression of GFP-tagged α5 subunits in cultured cortical neurons 
indicated that the H105R mutation does not appreciably affect expression and targeting 
11 
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of α5(H105R)-GABAA receptors in neurons. These results suggest that overexpressing 
α5(H105R) subunits in both HEK293 cells and neurons may override subtle 
impairments that lead to the partial loss of α5-GABAA receptors observed in 
α5(H105R) mice. 
In vivo, two different α subunits are frequently present in GABAA receptors e. g. α1 and 
α5. The subunit positioning defines the drug binding properties of GABAA receptors 
containing two different types of α subunits in a single receptor complex. Analysis by 
sucrose density gradient centrifugation and radioligand binding revealed a large fraction 
of misassembled α5(H105R)-GABAA receptors as indicated by their inability to bind 
ligands of the benzodiazepine site. In addition, in those α5(H105R)-GABAA receptors 
that assemble into ligand binding receptors the positioning of the α5(H105R) subunit in 
receptor complexes containing two distinct types of α subunits, e. g. α1 and α5, 
appeared to be changed. These findings imply an important role of histidine 105 in 
determining the position of the α5 subunit within the receptor complex 
Finally, the effect of a diminished α5-GABAA receptor expression on the activity of 
downstream signaling proteins important for learning and memory, which are under the 
control of NMDA receptors, was analyzed in the hippocampus. By Western blot 
analysis, reduced phosphorylation levels, i. e. activation states, selectively for CaMKII, 
MAPK p44/42 and CREB, with no change in their protein levels, were observed in 
α5(H105R) mice. Since a reduced expression of functional α5-GABAA receptors in the 
hippocampus is expected to result in a reduced inhibitory tone at spines of hippocampal 
pyramidal neurons and thus to an increased NMDA receptor activity, diminished 
activity of CaMKII, p44/42 MAPK and CREB may compensate for a chronically 
enhanced NMDA receptor response and thus may represent an adaptive response. 
 
 Introduction 
 
3 Introduction 
The central nervous system operates by a fine-tuned balance between excitatory and 
inhibitory signaling. The most abundant inhibitory neurotransmitter is GABA, which 
acts at ionotropic GABAA and metabotropic GABAB receptors (reviewed by Bormann 
2000). GABAergic function is modulated on several levels, including transmitter 
synthesis by two isoforms of glutamic acid decarboxylase (GAD) (Soghomonian and 
Martin 1998), vesicular storage (Dumoulin et al. 1999), Ca2+-dependent and 
independent release (Wall and Usowicz 1997), re-uptake in neurons and glial cells 
(Borden 1996, Quick et al. 1997) as well as activation of multiple receptors localized 
pre-, post- and extrasynaptically (Fritschy and Brünig 2003, Lüscher and Keller 2004). 
The significance of GABAergic inhibition is reflected in multiple neurological and 
psychiatric diseases such as epilepsy (Olsen et al. 1999), anxiety disorders (Malizia et 
al. 1999), ethanol dependence (Morrow et al. 2001), Huntington’s disease (Kunig et al. 
2000), Angelman syndrome (DeLorey et al. 1998) and schizophrenia (Nutt and Malizia 
2001). In addition to being key sites for synaptic inhibition, GABAA receptors are 
important drug targets, including benzodiazepines, barbiturates, some general 
anesthetics and ethanol (Dilger 2002, Mohler et al. 2002, Rudolph and Mohler 2006). 
3.1 Structure of GABAA receptors 
GABAA receptors are members of the ligand-gated ion channel superfamily that 
includes nicotinic acetylcholine receptors (nAChRs), glycine receptors and the serotonin 
5-hydroxytryptamine type 3 receptors (5-HT3R). This family of receptors is activated by 
presynaptically released ligands, which induce conformational changes in the receptor 
protein that opens the integral membrane-spanning ion-channel (Fig. 1). This results in 
an inward or outward flow of ions, depending on the electrochemical gradient of the 
ion. GABAA receptors are primarily permeable for chloride ions, although bicarbonate 
ions can cross the channel pore as well. Structurally, GABAA receptors are pentameric 
assemblies constructed from subunits derived from related genes or gene families 
(McDonald and Olsen 1994). Each subunit contains a large extracellular domain 
containing the ligand binding sites, four transmembrane spanning domain and a large 
intracellular loop connecting transmembrane domains three and four (Fig. 1). Subunits 
that are building blocks for GABAA receptors involve α(1-6), β(1-3), γ(1-3), δ, ε, π, θ 
and ρ(1-3) with further variation resulting from alternative splicing (Barnard et al. 
13 
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1998). The combinatorial assembly of these various subunits could lead to an enormous 
molecular heterogeneity of GABAA receptor subtypes; however certain subunit 
combinations are preferred (McKernan & Whiting 1996). The most abundant native 
receptors are formed from α1, β2 and γ2 subunits (Benke et al. 1991, McKernan and 
Whiting 1996). The likely stoichiometry is 2 α, 2 β and 1 γ subunit arranged around the 
ion channel (Tretter et al. 1997). The δ, ε, π and θ subunits are believed to substitute for 
the γ subunit in such receptor assemblies (Fig. 1). In addition, receptors with different 
subunit compositions are distributed to different cellular locations, where they are 
positioned to mediate primarily synaptic or extrasynaptic signaling (reviewed by Farrant 
and Nusser 2005, Fritschy and Brunig, 2003). 
 
Figure 1. Structure of GABAA receptor. (A) Each receptor subunit contains four hydrophobic 
transmembrane (TM) domains. The large N-terminal domain is located extracellularly and 
incorporates the neurotransmitter binding sites. The intracellular domain (cytoplasmic loop) 
between TM3 and TM4 is the most divergent part of individual receptor subunits and contains 
consensus sites for various protein kinases. The transmembrane domain TM2 is believed to 
form the lining of the ion channel. (B) Proposed pentameric structure of GABAA receptor. The 
TM2 domains (in green) are composed of either neutral or positively charged basic residues, 
which are thought to contribute to the anion selectivity of this channel. (C) Most GABAA 
receptors are composed of α, β and γ subunits in stoichiometry of 2:2:1. The δ, ε, θ can replace 
the γ subunit in some receptor subtypes. Adapted from Moss and Smart (2001). 
14 
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3.2 GABAA receptor assembly 
The pentameric GABAA receptors are built out of 16 different subunits and theoretically 
have the potential for an enormous structural diversity (theoretically 165 distinct 
subtypes). Despite this potential, relatively few functional receptor complexes have 
been identified in vivo (McKernan and Whiting 1996). Limiting receptor diversity could 
be a consequence of brain-region-specific and temporal expression of different subunits, 
but many neuronal cell types express simultaneously different subunit subtypes (Wisden 
and Seeburg 1992, Smith et al. 1998). This implies the existence of subcellular 
mechanisms for differential receptor assembly. There seems to be a combination of the 
discrete sites for receptor assembly present in each GABAA receptor subunit (Job and 
Eberwine 2001). Specific amino acid sequences present in the N-termini of the subunits 
have been found to control GABAA receptor subunit oligomerization (reviewed by 
Kittler et al. 2002). A domain in the α1 subunit, which is conserved in all α subunit 
isoforms (amino acids 58-67), is essential for association of the α1 with the β3 subunit 
(Taylor et al. 2000). Additionally, W69 and W94 have been identified to play an 
important role in the assembly of GABAA receptors and are common to all subunits of 
the ligand-gated ion channel family (Srinivasan et al. 1999). In the γ2 subunit, the 
amino acids 83-90 were identified as crucial for the assembly with β3 subunits and 
amino acids 91-104 for the assembly with α1 subunits (Klausberger et al. 2000). 
Reciprocally, in α1 subunits this corresponded to amino acids 80-100 (Klausberger et 
al. 2001). In addition, alanine 108 in the α1 subunit was found to be important for the 
formation of assembly intermediates with β3 and γ2 subunits (Sarto-Jackson et al. 
2006). On the basis of these experimental findings it has been suggested that the α1 
subunit contains at least three distinct subunit-binding sites: two binding sites on 
opposite faces of the N-terminal domain mediate assembly with β3 subunits and on one 
face there is an additional binding site for γ2 subunits (Klausberger et al. 2001). This 
would allow the α1 subunit to bind either two β3 subunits or one β3 and one γ2 subunit. 
Furthermore, Klausberger et al. (2001) suggest that the single α1-γ2 inter-subunit 
contact site controls the subunit assembly and stoichiometry of GABAA receptors.  
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3.3 GABAA receptor targeting to the cell surface 
For most GABAA receptor subunits, assembly into hetero-oligomeric complexes 
facilitates access to the cell surface. Studies on recombinant GABAA receptors 
composed of various subunit combinations revealed that access to the cell surface is 
limited to αβ and αβγ subunit combinations. Single expressed subunits and αγ or βγ 
combinations are retained within the endoplasmatic reticulum (ER) (reviewed by Kittler 
et al. 2002). Most importantly, αβγ receptors are assembling at the expense of αβ 
formation when all three subunits are present (Bollan et al. 2003).  
The quality control for correctly assembled receptors occurs in the ER, where subunits 
associate with chaperone molecules such as calnexin, BiP (heavy chain binding protein) 
and protein disulphide isomerase (Connoly et al. 1996, Gorrie et al. 1997). Calnexin 
recognizes immature glycans, BiP exposed hydrophobic regions and the isomerase 
catalyses disulphide bridges formation. Incorrectly assembled receptors are bound to 
BiP and calnexin and retained in ER via luminal KDEL retention signals within the 
chaperone proteins until being degraded. Correctly assembled receptors are released 
from the ER and travel to the cell surface. Retention of GABAA receptors in the ER 
may also serve to regulate the availability of particular subunits for assembly and 
subsequent insertion of new GABAA receptors into synapses (Kittler et al. 2000). 
Because both the N-terminus and the C-terminus of GABAA receptor subunits extend 
outside of the cell membrane, the intracellular loop located between transmembrane 
spanning domains TM3 and TM4 (Fig. 1) is the most important domain interacting with 
proteins involved in regulating the synaptic localization and intracellular trafficking 
(Fig. 2). These proteins have been shown to play important roles in modulating the 
activities of GABAA receptors ranging from enhancing trafficking (GABARAP) to 
stabilizing surface (Plic-1) and internalized receptors (HAP1) (reviewed by Chen and 
Olsen 2007). Associated proteins can influence the surface number of GABAA receptors 
(GABARAP, GRIP, BIG2, NSF) as well as guide the receptors to the synaptic 
(gephyrin) or extrasynaptic sites (radixin) (Kittler and Moss 2003, Chen and Olsen 
2007). Accompanied by interacting proteins, the GABAA receptors traffic along 
microtubules from intracellular compartments to the plasma membrane (Wang and 
Olsen 2000), move between synapses and extrasynaptic sites (Thomas et al. 2005) and 
finally internalize from the plasma membrane to the degradation pathway (Kittler et al. 
2000) (Fig. 2).  
16 
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mutierte als auch wildtyp α5-GABAA-Rezeptoren nach transienter Expression in 
HEK293 Zellen ein vergleichbares Expressionsniveau und ein ähnliches 
Zellöberflächen-Targeting aufwiesen. Darüber hinaus zeigte die Expression von GFP-
markierten α5-Untereinheiten in kultivierten Neuronen, dass die H105R-Mutation die 
Expression und das Targeting der α5(H105R)-GABAA Rezeptoren nicht spürbar 
beeinflusst. Diese Resultate deuten darauf hin, dass die Überexpression der α5(H105R)-
Untereinheiten in HEK293-Zellen und in Neuronen subtile Beeinträchtigungen 
verdecken, die zum partiellen Verlust der α5-GABAA-Rezeptoren in den α5(H105R) 
Mäusen führen. 
In vivo sind häufig zwei unterschiedliche α-Untereinheiten in einem GABAA-
Rezeptorkomplex anzutreffen (z. B. α1 und α5), wobei die Positionierung der 
jeweiligen α-Untereinheiten in Bezug zur γ2-Untereinheit die Liganden-
Bindungseigenschaften dieser GABAA-Rezeptoren definiert. Eine Analyse mittels 
Saccharose-Dichtegradienten und Radioligand-Bindungsexperimenten zeigte, dass ein 
grosser Anteil von α5(H105R)-GABAA Rezeptoren offensichtlich fehlerhaft 
assembliert war, da sie Liganden der Benzodiazepin-Bindungsstelle nicht mehr binden 
konnten. Weiterhin weisen Immunpräzipitations-Experimente darauf hin, dass in 
Rezeptoren die zwei unterschiedliche α-Untereinheiten enthielten (α1 und α5), die 
Positionierung der α-Untereinheiten verändert war. Diese Resultate deuten auf eine 
wichtige Rolle des Histidinrestes 105 der α5-Untereinheit in der korrekten 
Assemblierung von α5-GABAA-Rezeptoren hin. 
Abschliessend wurde der Effekt einer reduzierten α5-GABAA-Rezeptorexpression in 
den α5(H105R)-Mäusen auf die Expression und Aktivität von Signalproteinen 
untersucht, die eine wichtige Rolle in NMDA-Rezeptor kontrollierten Lern- und 
Gedächtnisprozessen spielen. Eine Western-Blot-Analyse ergab einen reduzierten 
Phosphorylierungszustand, d. h. Aktivierungsgrad, von CaMKII, MAPK p44/42 und 
CREB in den α5(H105R)-Mäusen bei gleichbleibendem Expressionsniveau dieser 
Proteine. Eine reduzierte Expression von α5-GABAA-Rezeptoren im Hippocampus 
führt voraussichtlich zu einem verminderten inhibitorischen Tonus in den 
Pyramidenzellen und bedingt vermutlich eine erhöhte Aktivität des NMDA Rezeptors. 
Daher könnte die beobachtete reduzierte Aktivität von CaMKII, MAPK p44/42 und 
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Figure 2. GABAA receptor trafficking is facilitated by receptor-associated proteins. 
GABAA receptors are assembled in the ER and αβ as well as αβγ subunit combinations are able 
to transit to the Golgi apparatus. Protein interactions in the Golgi apparatus are believed to 
facilitate intracellular transport of the receptor. At synaptic sites, GABAA receptors colocalize 
with the scaffold protein gephyrin, whereas at extrasynaptic sites α5-GABAA receptors interact 
with radixin. GABAA receptors are internalized via clathrin-coated pits. Abbreviations: HAP, 
Huntingtin-associated protein; Plic-1, proteins that link integrin associated protein to the 
cytoskeleton; NSF, N-ethylmaleimide-sensitive factor; GRIP, glutamate receptor interacting 
protein; PRIP, phospholipase C-related inactive proteins; GABARAP, GABA receptor 
associated protein; GRIF, GABAA receptor interacting factor; GODZ, Golgi-specific zinc finger 
protein; BIG2, brefeldin A-inhibited GDP/GTP exchange factor 2. Adapted from Kittler and 
Moss (2003) and Chen and Olsen (2007). 
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3.4 Pharmacology and distribution of GABAA receptor subtypes 
GABAA receptors are important drug targets since their malfunction is involved in 
human diseases such as epilepsy, anxiety disorders, ethanol dependence, Huntington’s 
disease and schizophrenia (reviewed by Mohler 2006). There are several drugs in 
clinical use, which specifically interact with GABAA receptors, such as 
benzodiazepines, barbiturates and some anesthetics (reviewed by Rudolph and Mohler 
2006). These compounds are allosteric modulators, which bind to distinct sites on the 
receptor to increase its activity and therefore enhance inhibitory synaptic transmission. 
Benzodiazepines are widely used for their anxiolytic, sedative, hypnotic, muscle 
relaxant and anticonvulsant action (reviewed by Whiting 2003) and moreover have 
proved to be important research tool for analyzing the functional role of GABAA 
receptor subtypes. 
The majority of GABAA receptors are characterized by their sensitivity to the clinically 
important agonist of the benzodiazepine site, e.g. diazepam. These receptors contain the 
α1, α2, α3 or α5 subunit in combination with a β and the γ2 subunit. The binding 
pocket for benzodiazepines is located the interface of the γ2 and α1, α2, α3 or α5 
subunits. This position is homologous to the GABA binding site, which is located 
between α and β subunits (Fig. 3) (Boilleau et al. 1999, Teissere and Czajkowski 2001). 
Interestingly, there is an overlap of the identified assembly signals in the α and γ 
subunits and the benzodiazepine binding site (Klausberger et al. 2000, Sarto et al. 
2002). 
GABAA receptors that do not respond to agonists of the benzodiazepine site are of low 
abundance in the brain and characterized mainly by the α4 and α6 subunits. Diazepam 
sensitivity of GABAA receptors depends on the presence of a histidine residue in the 
drug-binding domain of α1, α2, α3 and α5 subunits, whereas α4 and α6 subunits 
contain at the homologous position an arginine residue (Wieland et al. 1992, Benson et 
al. 1998). This feature has been used to analyze the contribution of GABAA receptor 
subtypes to the diverse actions of diazepam by generating mouse lines that contain a 
histidine to arginine point mutation in the α1, α2, α3 and α5 subunits (Rudolph et al. 
1999, McKernan et al. 2000, Löw et al. 2000, Crestani et al. 2002). These studies have 
revealed that the sedative action of diazepam is mediated by α1-GABAA receptors, the 
18 
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anxiolytic action by α2-GABAA receptors and muscle relaxant activity partially by α3- 
as well as by α5-GABAA receptors (reviewed by Rudolph and Mohler 2004). 
The physiological significance of the structural diversity of GABAA receptors is 
reflected in differences of their channel kinetics, affinity for GABA, rate of 
desensitization and interaction with other proteins (reviewed in Mohler 2006). In 
addition, receptor subtypes differ in their distribution throughout the brain, partially 
show a cell-type specific expression and when present in the same neuron display very 
often a domain-specific location (Tab. 1, Fig. 4). GABAA receptors can be roughly 
divided into preferentially synaptic types that contain the γ2 subunit and mediate phasic 
inhibition and extrasynaptic receptor subtypes that contain the δ subunit and contribute 
selectively to tonic inhibition (reviewed in Farrant and Nusser 2005). However, this rule 
does not account for α5-containing receptors, which assemble with the γ2 subunit and 
are mostly localized extrasynaptically were they mediate tonic inhibition (Brünig et al. 
2002, Crestani et al. 2002).  
 
 
 
Figure 3. Model of a pentameric GABAA receptor comprising two α, two β and the γ2 
subunit (top-view). The binding sites for GABA and benzodiazepines (BZ) are located at the 
interface of α/β and α/γ2 subunits, respectively. Adapted from Ernst et al. (2005). 
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Figure 4. Distribution of GABAA receptor α subunits. The four classes of diazepam-sensitive 
GABAA receptors are distinguished by the type of α-subunit (α1, α2, α3, α5) and their largely 
distinct neuronal localizations as demonstrated immunohistochemically in mouse brain sections. 
White color indicates high subunit abundance while blue indicates low subunit abundance. 
(from Mohler et al. 2002). 
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Table 1. Function and distribution of GABAA receptor subtypes in the brain (Mohler 2006) 
    
Receptor 
composition 
Pharmacological 
characteristics 
Regional and neuronal localization Subcellular 
localization 
α1β2γ2 Major GABAA receptor 
subtype (60 %). Mediates 
the sedative, amnesic and 
anticonvulsant action of 
benzodiazepine site 
agonists. High affinity for 
classical benzodiazepines, 
zolpidem and the 
antagonist flumazenil. 
Cerebral cortex (layer I-VI, selected 
interneurons and principal cells); 
hippocampus (selected interneurons 
and principal cells); pallidum 
striatum (interneurons); cerebellum 
(Purkinje and granule cells); deep 
cerebellar nuclei; amygdala; basal 
forebrain; substanitia nigra pars 
reticulate; inferior colliculus; 
brainstem. 
Synaptic (soma and 
dendrites) and 
extrasynaptic in all 
neurons with high 
expression. 
α2β3γ2 Minor subtype (15-20 %). 
Mediates anxiolytic action 
of benzodiazepine site 
agonists. High affinity for 
classical benzodiazepine 
agonists and the 
anatagonist flumazenil. 
Intermediate affinity for 
zolpidem. 
Cerebral cortex (layers I-IV); 
hippocampus (principal cells); 
olfactory bulb (granule cells); 
striatum (spiny stellate cells); 
inferior olivary neurons (dendrites); 
hypothalamus; amygdala (principal 
cells); superior colliculus; motor 
neurons. 
Mainly synaptic, 
enriched in axon 
initial segment of 
cortical and 
hippocampal 
pyramidal cells. 
α3βnγ2 Minor subtype (10-15 %). 
High affinity for classical 
benzodiazepine agonists 
and the antagonist 
flumazenil. Intermediate 
affinity for zolpidem. 
Cerebral cortex (principal cells in 
layers V and VI, some axon initial 
segments); hippocampus (some hilar 
cells); olfactory bulb (tufted cells); 
thalamic reticular neurons; 
cerebellum (Golgi type II cells); 
medullary reticular formation; 
inferior olivary neurons; amygdala; 
superior colliculus; brainstem; spinal 
cord; medial septum; basal forebrain 
cholinergic neurons; raphe and locus 
coeruleus (serotoninergic and 
catecholaminergic neurons). 
Mainly synaptic, 
including some axon 
initial segments; 
extrasynaptic in 
inferior olivary 
neurons. 
α4βnδ Less than 5 % of all 
receptors. Insensitive to 
classical benzodiazepine 
agonists and zolpidem. 
Dentate gyrus (granule cells); 
thalamus. 
Extrasynaptic (no 
direct morphological 
evidence). 
α5β3γ2 Less than 5 % of all 
receptors. High affinity for 
classical benzodiazepine 
agonists and antagonist 
flumazenil. Low affinity 
for zolpidem. 
Hippocampus (pyramidal cells); 
olfactory bulb (granule cells, 
periplomerular cells); cerebral 
cortex; amygdala; hypothalamus; 
superior colliculus; superior olivary 
neurons; spinal trigeminal neurons; 
spinal cord. 
Extrasynaptic in 
hippocampus, 
cerebral cortex, 
olfactory bulb. 
Synaptic and 
extrasynaptic in 
spinal trigeminal 
nucleus and superior 
olivary nucleus. 
α6β2,3γ2 Less than 5 % of all 
receptors. Insensitive to 
classical α6β2,3δ  
benzodiazepine agonists 
and zolpidem. 
Cerebellum (granule cells); dorsal 
cochlear nucleus. 
Synaptic (cerebellar 
glomeruli) and 
extrasynaptic on 
granule cell 
dendrites and soma. 
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3.5 Function of GABAA receptor subtypes 
The identification of the pharmacological relevance of GABAA receptors has been 
achieved by genetic and medicinal chemistry tools. The genetic approach involved the 
generation of mouse lines either lacking individual receptor subunits or rendering 
individual subunits insensitive to the clinically important benzodiazepine site drug 
diazepam (reviewed by Rudolph and Mohler 2004). The medicinal chemistry approach 
focused on the development of ligands with selective affinity or efficacy for individual 
GABAA receptor subtype (Sternfeld et al. 2004, Chambers et al. 2004, Atack et al. 
2005). 
3.5.1 α5-GABAA receptor knock-out mice 
The function of GABAA receptor subtypes has been investigated using knock-out and 
knock-in mouse lines. Since the present study focuses on α5-GABAA receptors, the 
strategies for their investigation will be described in more detail. Knock-out mouse lines 
for α subunits were generated for α1, α3, α5 and α6 subunit. With the exception of the 
α3 and α5 subunit knock out mice, all other lines exerted compensatory changes in the 
expression of other receptor subunits, compromising the interpretation of the phenotype 
in terms of receptor subtype function (Rudolph and Mohler 2004). In α5 knock out 
mice, the number of benzodiazepine-binding sites in the hippocampus decreased by 
16%, which corresponds roughly to the number of α5-GABAA receptors in this brain 
region and suggests no significant up-regulation of other α subunits (Collinson et al. 
2002). Behaviorally, these mice display an improved performance in the Morris water 
maze test, a spatial learning task dependent on hippocampal function (Collinson et al. 
2002). This result was also confirmed with an inverse agonist selective for α5-GABAA 
receptors that enhanced performance of rats in the water maze test without any 
convulsant activity (Chambers et al. 2003). 
3.5.2 α5-GABAA receptor knock-in mice 
Studies with knock-out mice have shown that elimination of individual α subunits may 
lead to adaptive compensatory changes during development. To overcome these 
problems, a point mutation strategy had been developed, which retained the 
physiological function of the targeted receptor subtype but prevented the modulation of 
receptor activity by defined drugs. This strategy was perfectly suited for dissecting the 
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contribution of GABAA receptors subtypes to the various actions of diazepam, e.g. 
sedation, muscle relaxation, anticonvulsant activity and anxiolysis. Since α subunits 
containing a histidine residue in the drug-binding domain (α1H101, α2H101, α3H126, 
α5H105) convey diazepam-sensitivity to the receptor complex and α subunits with an 
arginine residue (α4R99, α6R100) diazepam-insensitivity, a histidine to arginine point 
mutation in α1, α2, α3 or α5 subunits consequently renders the respective GABAA 
receptor subtypes insensitive to the actions of diazepam. Generation and analysis of 
α1(H101R), α2(H101R), α3(H126R) and α5(H105R) knock-in mice revealed first 
insights in the function of GABAA receptors subtypes in vivo (Rudolph et al. 1999, Löw 
et al. 2000, McKernan et al. 2000, Crestani et al. 2002). The α1-containing GABAA 
receptors represent the major subtype (~60% of diazepam-sensitive GABAA receptor 
subtypes) and are expressed in virtually all main brain areas (Tab. 1). In α1(H101R) 
mice the sedative action and the anterograde amnesic action of diazepam was absent, 
indicating that they are mediated through the α1-GABAA receptor subtype in the wild 
type mice (Rudolph et al. 1999). The α2 subunit-containing GABAA receptors represent 
15-20% of diazepam-sensitive GABAA receptors and display a more restricted 
distribution in brain with particular prominent expression in the limbic system (Tab. 1). 
Most interestingly, α2(H101R) mice lacked anxiolytic and partially myorelaxant actions 
of diazepam (Löw et al. 2000, Crestani et al. 2001). Thus, two major clinically 
important effects of diazepam are mediated by two distinct GABAA receptor subtypes: 
sedation by α1-GABAA receptors and anxiolysis by α2-GABAA receptors. In addition, 
the myorelaxant action of diazepam was reduced in α3(H126R) and α5(H105R) mice, 
indicating that these receptor subtypes are involved in this effect of diazepam (Löw et 
al. 2000, Crestani et al. 2001, 2002). 
Immunoblotting, immunohistochamistry and immunofluorescence experiments 
confirmed the initial expectations that the introduction of the point mutation into the 
receptor subunits did not change their expressed levels or their regional and subcellular 
distributions (Rudolph et al. 1999, Löw et al. 2000). The only exception was the 
α5(H105R) mouse line, in which the regional and subcellular localization of the α5 
subunit remained unaffected but its expression level in the hippocampus was found to 
be moderately reduced (20%, Crestani et al. 2002). Interestingly, the partial deficit of 
α5-GABAA receptors in the hippocampus resulted in selective changes in learning and 
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memory performance. α5(H105R) mice exhibited an improved memory performance in 
a trace fear conditioning paradigm (Crestani et al. 2002) and were resistant to extinction 
of conditional fear (Yee et al. 2004). This indicates that α5-GABAA receptors, which 
are mostly expressed extrasynaptically in hippocampus, play a role in the temporal 
association of threat cues in trace fear conditioning (Crestani et al. 2002).  
3.6 NMDA receptor signaling cascade underlying learning and memory 
Interestingly, a deficit in hippocampal NMDA receptors produces opposite effects on 
hippocamal learning and memory paradigms than deficits in hippocampal α5-GABAA 
receptors. For instance, mice lacking NMDA receptors in the CA1 region of the 
hippocampus failed to memorize threat cues in trace fear conditioning (Huerta et al. 
2000), while a deficit in a α5-GABAA receptors resulted in improved performance in 
this memory task (Crestani et al. 2002). Therefore, both receptors seem to accomplish 
complementary functions in regulating learning and memory. Since α5-GABAA 
receptors are largely located extrasynaptically at spines and shafts of pyramidal cell 
dendrites, they may directly control and modulate NMDA receptor mediated excitation 
at the spines. 
The hippocampus is critical for converting short-term memories into long-term 
memories (reviewed by McGaugh 2000). NMDA receptors play an important role in 
this process as shown by gain- and loss-of-function studies (Tang et al. 1999, Shimizu 
et al. 2000). NMDA receptors seem to be required for the induction, but not 
maintenance of synaptic activity and it is believed that consolidation at a synaptic level 
is the result of molecular cascades initiated by long-term potentiation triggered during 
learning (Bourtchuladze et al. 1994, Deisseroth et al. 1996, Atkins et al. 1998, reviewed 
by Silva et al. 1998, Bozon et al. 2003, reviewed by Thomas and Huganir 2004). One of 
the key proteins of the NMDA receptor-induced signaling cascade is the transcription 
factor CREB (cAMP responsive element binding protein). Genetic and pharmacological 
studies in rodents demonstrated that CREB is required for a variety of complex forms of 
memory, including spatial and social learning, indicating that CREB may be a universal 
modulator of processes underlying memory formation (reviewed by Silva et al. 1998). 
CREB is a member of a large family of structurally related transcription factors that 
bind to cAMP responsive element (CRE) sites in certain promoters to enhance gene 
transcription (reviewed by Lonze and Ginty 2002, Mayr and Montminy 2001). 
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Transcription factors from the CREB family contain domains that are required for 
transcriptional activation and domains that mediate dimerization and DNA binding. The 
activation domain includes a cluster of phosphorylation sites that regulate the activity of 
CREB. The crucial event in the activation of CREB is the phosphorylation of Ser133 by 
a variety of kinases and may be a mechanism for the convergence of several different 
signaling pathways. Thus, CREB activation can be detected in neurons using antibodies 
specific to phosphorylated Ser133 in the CREB protein (Deisseroth et al. 1996). Studies 
using this approach revealed that while NMDA receptor-dependent synaptic stimulation 
results in CREB phosphorylation, action potential firing alone does not (Deisseroth et 
al. 1996). This finding indicates that CREB phosphorylation is not a general marker for 
neuronal activity, but instead responds to specific synaptic signals. Although many 
kinases can phosphorylate CREB, specific kinases predominate in response to different 
stimuli. In neurons there is an evidence that the calmodulin kinase pathway is crucial for 
rapid activity-dependent phosphorylation of Ser133, whereas prolonged activity-
dependent phosphorylation is mediated by activation of the Ras-MAPK pathway (Wu et 
al. 2001). Eventually, calcium influx also leads to the dephosphorylation of CREB 
through activation of protein phosphatases (reviewed by West et al. 2002). Hardingham 
et al. (2002) showed that activation of synaptic NMDA receptors leads to the 
phosphorylation of CREB. In contrast, activation of extrasynaptic NMDA receptors 
dephosphorylates and inactivates CREB, possibly to prevent overactivation of CREB in 
case of overspill of synaptic glutamate. These studies indicate that CREB activation and 
consequently gene transcription is controlled and modulated by NMDA receptors in a 
complex manner. 
 
 
 
 
Aim of the study  
4 Aim of the study 
α5-GABAA receptors are most abundantly expressed in the hippocampus, where they 
mediate tonic inhibition and play an important role in learning and memory. Mice 
containing the (H105R) point mutation in the α5 subunit gene express reduced levels of 
the α5 subunit protein in the hippocampus, which resulted in enhanced trace fear 
conditioning (Crestani et al. 2002). Since α5 mRNA levels were not reduced, the 
mutation seems to influence posttranscriptional events such as synthesis, assembly, 
trafficking or degradation. To gain insights into how the α5(H105R) mutation affects 
α5-GABAA receptors, the present study aimed primarily at analyzing the effect of the 
mutation on the assembly and trafficking of α5-GABAA receptors. In addition, we 
intended to analyze the effect of a reduced expression of α5-GABAA receptors on the 
activity of downstream signaling proteins important for learning and memory.  
4.1 Analysis of α5-GABAA receptor targeting in HEK293 and neuronal cells 
Our first hypothesis was that the reduced α5 subunits protein levels were caused by an 
impaired trafficking of α5(H105R)-GABAA receptors. In order to monitor and compare 
targeting of α5- and α5(H105R)-GABAA receptors expressed in HEK293 cells and 
primary cultured neurons, we used immunocytochemistry and confocal laser scanning 
microscopy in combination with various tagging methods (antibody, GFP, biarsenical 
dye- and α-bungarotoxin-based tracking methods). 
4.2 Analysis of the α5-GABAA receptor assembly 
The second hypothesis for the reduced α5 subunit protein expression in α5(H105R) 
mice was that the mutation might be critical for the correct assembly of α5-GABAA 
receptors. Therefore we examined whether the H105R mutation might affect the 
assembly of the receptor, using sucrose density centrifugation analysis and radioligand 
binding experiments.  
4.3 Influence of α5-GABAA receptors on processes of learning and memory  
Previous studies have shown that deletion or reduction of α5-GABAA receptors 
enhanced spatial learning (Collinson et al. 2002) and temporal learning (Crestani et al. 
2002) in rodents. As an underlying mechanism, it has been proposed that extrasynaptic 
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α5-GABAA receptors modulate the excitatory input arising from NMDA receptors. 
Therefore, we investigated whether the reduction of α5(H105R)-GABAA receptors 
might affect the activity of signaling proteins, which are activated by NMDA receptors 
and are important for learning and memory.  
Methods  
5 Methods 
5.1 Animals 
In this study, 8-week old wild type (129/SvJ), α1(H101R) and α5(H105R) mice (> 10 
backcrosses to the 129/SvJ background) were used (Rudolph et al. 1999, Löw et al. 
2000, Crestani et al. 2002). Rat embryos (embryonic day E18) were obtained from time 
mated pregnant Wistar rats (RCC, Basel, Switzerland). All experiments were performed 
in accordance to international guidelines on animal care and use and were approved by 
the Cantonal Veterinary Office of Zurich. 
5.2 Plasmids 
The following cDNAs in the appropriate vectors were used in the present study:  
cDNA insert Vector Source/reference 
GABAA α1, rat pBC12/CMV-α1 Benson et al. 1998 
GABAA α1 (TetraCys), rat pβAct-α1TetraCys This study 
GABAA α1 (TetraCys, myc), 
rat pβAct-α1TetraCys-myc This study 
GABAA α1 (TetraCys, flag), 
rat 
pβAct-α1TetraCys-flag This study 
GABAA α5, rat pBC12/CMV-α5 Benson et al. 1998 
GABAA α5, rat pSP72-α5 Benson et al. 1998 
GABAA α5, rat pcDNA3.1-α5 This study 
GABAA α5 (btx), rat pcDNA3.1-α5-btx This study 
GABAA α5 (GFP), rat pCMV-α5-GFP Gift of Dr. A. Zeller 
GABAA α5(H105R)(GFP), rat pCMV-α5(H105R)-GFP This study 
GABAA β2, rat pBC12/CMV-β2 Benson et al. 1998 
GABAA β3, rat pBC12/CMV-β3 Benson et al. 1998 
GABAA γ2-long, rat pBC12/CMV-γ2 Benson et al. 1998 
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5.4 Cloning 
Cloning of the TetraCys tag into the α1 subunit 
The complementary oligonucleotides coding for the TetraCys tag (amino acid sequence 
CCPGCC, Adams et al. 2002) were synthesized (Microsynth) with nucleotide 
sequences GTGACCCCTGTTGTCCTGGCTGTTGCG (sense) and GTCACCG-
CAACAGCCAGGACAACAGGG (antisense). Both oligonucleotides had 5’ phosphate 
groups and were annealed to each other by heating to 95°C and slowly cooling down. 
The insert was subcloned into the BstEII site in the second intracellular loop of the α1 
subunit (amino acid 383) using the Ready-to-go ligation kit (Amersham). The 
α1TetraCys construct was then subcloned into the pβAct vector (containing the 
chicken-β-actin promoter) via HindIII and XbaI sites using the LigaFast rapid ligation 
kit (Promega). Plasmids were transformed into E. coli (XL-10 gold, Stratagene) and 
were isolated with the Nucleobond kit (Macherey-Nagel, Germany) according to 
manufacturer’s protocol. 
Cloning of myc and flag tags into the α1 subunit 
The myc or flag tag was introduced at the C-terminus of the α1TetraCys construct in the 
pβAct vector. The tags were appended using the forward primer CCCGTGAAGCT-
TATGAAGAAAAGTCGGGGTCTC and either the reverse primer AACTCTAGAC-
TACAGGTCCTCCTCTGAGATCAGCTTCTGCTCCTCTTGATGGGGTGTGGG for 
the myc tag or: AACTCTAGACTACTTGTCGTCGTCGTCCTTGTAGTCTTGATG-
GGGTGTGG for the flag tag. The new constructs were amplified by PCR with 50 ng 
template α1TetraCys-pβAct, 125 ng of forward and reverse primer, 0.2 mM dNTPs, 1.5 
mM Mg2+, 5 units Taq polymerase and reaction buffer (Invitrogen). The PCR was 
performed at a melting temperature of 55°C for 30 cycles (Mastercycler, Eppendorf). 
The α1TetraCys-myc and α1TetraCys-flag inserts were cut with HindIII and XbaI 
restriction enzymes and were subcloned via these sites into the pβAct vector using the 
LigaFast rapid ligation kit (Promega). Plasmids were transformed into E. coli (XL-10 
gold, Stratagene) and were isolated with the Nucleobond kit (Macherey-Nagel, 
Germany). 
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Cloning of the bungarotoxin (btx) tag into the α5 subunit 
The complementary oligonucleotides coding for minimal α-bungarotoxin binding site 
(amino acids WRYYESSLEPYPD, Sekine-Aizawa and Huganir 2004) were 
synthesized (Microsynth, sense: CTAGCTGGAGATACTACGAGAGCTCCCTGG-
AGCCCTAC-CCTGACA, antisense: CTAGTGTCAGGGTAGGGCTCCAGGGAGC-
TCTCGTAGTATCTCCAT). The two fragments contained 5’ phosphate group and 
were annealed to each other by heating to 95°C and slowly cooling down. The insert 
was subcloned into the SpeI site of the α5 subunit (amino acid 36) in the pSP72 cloning 
vector using the LigaFast rapid ligation kit (Promega). The α5btx construct was finally 
subcloned into the pcDNA3.1 vector (Invitrogen) via KpnI and BamHI sites (LigaFast 
rapid ligation kit, Promega). Plasmids were transformed into E. coli (XL-10 gold, 
Stratagene) and were isolated with the Nucleobond kit (Macherey-Nagel, Germany). 
Cloning of the α5(H105R)-GFP construct 
The GFP-tagged α5 subunit in the pBC12/CMV vector was a kind gift from Dr. A. 
Zeller. To generate the pBC12/CMV-α5(H105R)-GFP construct, the His at position 105 
was exchanged by Arg using site-directed mutagenesis. Oligonucleotides designed for 
this purpose contain the desired mutation (CAC into CGG) and anneal to the same 
sequence on opposite strands of the plasmid. The oligonucleotide sequences were as 
following: CCAGACACGTTCTTCCGGAACGGCAAGAAGTCC (sense) and 
GGACTTCTTGCCGTTCCGGAAGAACGTGTCTGG (antisense). Quick-change site-
directed mutagenesis was performed using PCR. The PCR mix contained 50 ng 
pBC12/CMV-α5-GFP template, 125 ng of each oligonucleotide, 0.2 mM dNTPs, 1 mM 
Mg2+, 2.5 units Pfu polymerase and reaction buffer (Promega). The PCR was performed 
at a melting temperature of 55°C for 16 cycles (Mastercycler, Eppendorf). The template 
DNA was digested using DpnI (BioLabs). The new plasmid carrying the point mutation 
was transformed into DH5α E. coli cells (Stratagene) and isolated with the Nucleobond 
kit (Macherey-Nagel, Germany). 
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5.5 Cell culture and transfection 
5.5.1 Culture and transfection of HEK293 cells 
Human embryonic kidney (HEK293) cells were cultured in minimal essential medium 
(MEM, Invitrogen) containing 10% fetal calf serum (Invitrogen). Transfection of 
HEK293 cells was performed using the calcium phosphate precipitation method 
according to Chen and Okayama (1987). The transfection solution for a 10 cm culture 
dish (Falcon) was prepared by filling up the appropriate DNA amount with water to a 
volume of 720 μl and supplemented with 80 μl 2.5 M CaCl2 and 800 μl BES buffer (50 
mM BES pH 6.9, 280 mM NaCl, 1.5 mM Na2HPO4). The mixture was incubated for 15 
min at room temperature and added dropwise to the plated cells. In a 3 cm culture dish 
the amount of transfection solution was scaled down 10-fold. After addition of the 
transfection solution, the cells were incubated overnight at 35°C and 3% CO2. The next 
day, the cells were washed with PBS and maintained in the fresh culture medium for 48 
h at 37°C and 5% CO2. For immunofluorescence staining, HEK293 cells were plated at 
a density of 0.5 x 106 cells per 3 cm culture dish and transfected with a total amount of 4 
μg of DNA per dish.  
5.5.2 Culture of cortical neurons 
Primary cultures of cortical neurons were prepared from rat embryos taken at embryonic 
day E18 from pregnant wistar rats. The cortex was dissected on ice in PBG buffer (PBS 
pH 7.4, 10 mM glucose) and incubated for 15 min at 37°C in papain solution (PBS pH 
7.4, 10 mM glucose, 1 mg/ml bovine serum albumin, 10 ug/ml DNAse-I, 0.5 mg/ml 
papain). Subsequently neurons were dissociated by gentle trituration with a fire-
polished Pasteur pipette and suspended in DMEM (Invitrogen) containing 10 % fetal 
calf serum (Invitrogen). Neurons were plated to a density of 40 000 to 60 000 onto poly-
L-lysine coated (100 μg/ml) glass coverslips (∅ 15 mm, 0.17 ± 0.02 mm thickness, Karl 
Hecht Glaswarenfabrik, Germany). The neurons were cultured either in the absence or 
in presence of a glial feeder layer. 
Without glial feeder layer: after one hour, neurons were attached to the coverslips and 
transferred to a 12-well plate in the same medium (1 ml). After 24 hours, the medum 
was replaced with NB medium (Neurobasal medium (Invitrogen) containing B27 
supplement 1:50 (Invitrogen), GlutaMAX 1:100 (Invitrogen), antimycoticum 
/antbioticum 1:100 (Invitrogen), FUDR 1:1000 (fluorodeoxyuridine 10 mM and uridine 
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10 mM, Sigma; to stop glial cell proliferation). Cultures were kept at 37°C and 5 % CO2 
in a humidified incubator. 
With glial feeder layer: glial cells, prepared from rat cortex of postnatal day 0 (P0), 
were plated in advance in 12-well plates and cultured in DMEM containing 10 % fetal 
calf serum to generate a feeder layer. After preparation of cortical neurons, the glial cell 
culture medium was exchanged with a defined serum-free medium (Brewer and 
Cotman, 1989) and neurons, after attaching to coverslips for one hour, were placed 
above the feeder layer. Cultures were kept at 37°C and 10 % CO2 in a humidified 
incubator. 
5.5.3 Transfection of primary cortical neurons 
Nucleofection 
Freshly dissociated cortical neurons were transfected by means of the Amaxa 
nucleofection technology (Amaxa Biosystems, Germany) according to manufacturer’s 
protocol using 2 μg DNA and electroporation program O-03. After nucleofection, 
neurons were plated at a density of 30-40 000 per cover slip (∅ 18 mm) and kept under 
the same conditions as nontransfected cells. 
NeuroFect 
Cortical neurons were grown for 4-6 days and transfected with the NeuroFect 
transfection agent (Genlantis, San Diego, CA). In separate tubes, 1 μg of NeuroFect 
diluted in 50 μl serum free medium (OptiMEM, Invitrogen) and 1 μg DNA in serum 
free medium were prepared. The diluted NeuroFect was added dropwise to the DNA 
solution followed by gentle mixing. The NeuroFect/DNA solution was incubated for 
15-20 min at room temperature to allow the formation of polyplexes. Old culture 
medium was removed from neurons and replaced with 400 μl fresh medium and 100 μl 
NeuroFect/DNA solution was added on top. Transfected neurons were incubated at 
37°C and 5 % CO2 and gene expression was assayed 24-48 h post transfection. 
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5.6 Immunocytochemistry 
5.6.1 Conventional double and triple labeling immunocytochemistry and confocal 
microscopy 
Double and triple labeling immunocytochemistry was performed on HEK293 cells and 
primary cortical neurons. Cells were fixed for 10 min with 4% paraformaldehyd and 4 
% sucrose in 150 mM phosphate buffer pH 6.8-7.4 (PFA) and washed three times in 
phosphate buffered saline pH 7.4 (PBS). For labeling of both surface and intracellular 
proteins, cells were permeabilized for 5 min with 0.5% Triton X-100 in PBS and 
washed once with PBS. Labeling was achieved by incubating cells with a primary 
antibody diluted in PBS containing 10% normal goat serum (NGS). After washing three 
times for 10 min in PBS, cells were incubated with secondary antibody coupled to a 
green (Alexa green 488, Molecular Probes, 1:1000), red (Cy3, Jackson 
ImmunoResearch, 1:500) and/or blue (Cy5, Jackson ImmunoResearch, 1:100) 
fluorescent fluorophore. Cells were washed again three times in PBS to remove 
unbound antibodies and mounted on glass slides with mounting medium (DAKO 
Cytomation, Carpinteria). Specimens were analyzed with a confocal laser scanning 
microscope (Axioplan2, LSM 510 Meta, Carl Zeiss AG, Germany) equipped with a 
100x oil immersion objective (N.A. 1.4). Images were acquired by sequential scanning 
of the emission lines and using the full dynamic range of the photodetectors. Digital 
images were processed using the software Imaris, version 4.1 (Bitplane, Switzerland). 
For display, minimal linear contrast adjustments were made. 
5.6.2 Biarsenical dye labeling 
Prior to labeling, HEK293 cells or primary cortical neurons expressing the α1TetraCys 
construct were washed once with PBS buffer. Lumio green and Limio red dyes 
(Invitrogen) were diluted in PBS buffer containing 1 mM pyruvic acid, 10 μM 1,2-
ethanedithiol (EDT2, Fluka), and added to the cells to a final concentration of 1 µM 
(Lumio green) and 2.5 μM (Lumio red). Incubation proceeded for 45 min at 37°C or at 
room temperature in a humid chamber. To remove unbound Lumio dyes, cells were 
washed five times for 5 min with PBS containing 250 μM EDT2. Cells were then fixed 
with PFA and processed for further antibody staining as described above.  
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5.6.3 Alexa-Fluor488-α-bungarotoxin labeling 
Living HEK293 cells or cortical neurons transfected with α5btx constructs were labeled 
with 1 μg/ml Alexa-Flour488-conjugated α-bungarotoxin (Invitrogen) diluted directly 
into the cell culture medium. Cells were incubated for 30 min in a humid chamber at 
37°C and 5 % CO2. After labeling, the cells were washed three times with prewarmed 
buffer (2 mM CaCl2, 2 mM MgCl2, 1 uM glycine, 5 mM KCl, 119 mM NaCl, 25 mM 
HEPES, 30 mM glucose, pH 7.4). Subsequently, the cells were fixed with PFA and 
further processed for antibody staining as described above. 
Labeling of transfected cortical neurons additionally included a preincubation step with 
tubocurarine (10 μg/ml) for 15 min at 37°C and 5 % CO2 to block endogenous α-
bungarotoxin binding sites of α7 nicotinic acetylcholine receptors. 
5.7 Cell surface enzyme-linked immunosorbent assay (ELISA) 
HEK293 cells grown on 10 cm culture dishes were transiently transfected with the 
subunit combinations α5β3γ2 or α5(H105R)β3γ2 using a total of 20 μg DNA and 
splitted after 24 h onto 96-well plates (Nunc). After further 48 h, cells were fixed with 
PFA. For cell surface staining of α5-GABAA receptors, cells were washed in PBS and 
incubated with α5 antibody (1:2000) diluted in PBS/10% NGS for 1 hour at room 
temperature. Cells were then washed three times for 10 min with PBS and incubated 
with horseradish-peroxidase conjugated anti-guinea pig antibody (1:1000) for 1 hour at 
room temperature. Cells were again extensively washed and the activity of horseradish-
peroxidase was detected using tetramethylbenzidine as a substrate (100 μl/well; 0.24 
mg/ml tetramethylbenzidine, 0.2 M sodium citrate pH 3.95, 0.03 % H2O2). The 
colorimetric reaction was terminated after 20-30 min by adding 100 μl 2 M H2SO4 and 
the optical density was recorded at 450 nm in a microplate reader (Synergy HT, Biotek). 
Total expression of α5 subunit was determined in cells that were permeabilized with 0.5 
% Triton X-100 for 5 min at room temperature after fixation with PFA. Nonspecific 
antibody reaction was determined in parallel cultures of non-transfected cells. 
5.8 Membrane preparation 
Brains from 8-week-old mice were homogenized in 10 volumes of 10 mM Tris-HCl, pH 
7.4, 0.32 M sucrose, 5 mM EDTA, 0.02 % NaN3, protease inhibitors (complete mini, 
Roche), 0.1 mM phenylmethylsulphonyl fluoride and centrifuged at 1000 x g for 10 
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5.3 Antibodies 
The following antibodies were used in this study:  
Name Type Dilution Source/Reference 
α1 pR Ab 1:5000 IF Fritschy & Mohler 1995 
α1C  pR Ab 1:20 IP Benke et al. 1991 
α2C  pR Ab 1:20 IP Marksitzer et al. 1993 
α3N pR Ab 1:15 IP Benke et al. 1991 
α5 pGP Ab 1:3000 IF 
1:2000 WB  
1:2000 ELISA 
Fritschy & Mohler 1995 
β2/3 (clone BD17) mM Ab 1:4000 IF 
1:2000 WB 
Schoch et al. 1985  
β-actin mM Ab 1:10000 WB Chemicon 
CaMKII pR Ab 1:1000 WB Cell Signaling 
CREB pR Ab 1:1000 WB Cell Signaling 
Flag mM Ab 1:2000 IF Sigma-Aldrich 
γ2 pGP Ab 1:2000 IF 
1:2000 WB 
Fritschy & Mohler 1995 
GFP mM Ab 1:1000 IF Clontech 
Myc (clone 9E10) mM Ab 1:4000 IF Sigma-Aldrich 
p44/42 MAPK pR Ab 1:1000 WB Cell Signaling 
phospho-CaMKII(Thr 286) pR Ab 1:1000 WB Cell Signaling 
phospho-CREB(Ser133) pR Ab 1:1000 WB Cell Signaling 
phospho-38MAPK(Thr180/Tyr182) pR Ab 1:1000 WB Cell Signaling 
phospho-PKCδ(Thr 505) pR Ab 1:1000 WB Cell Signaling 
phospho-PKCε(Ser 719) pR Ab 1:1000 WB Cell Signaling 
phospho-
SAPK/JNK(Thr183/Tyr185) 
pR Ab 1:1000 WB Cell Signaling 
phospho-Src(Tyr 416) pR Ab 1:1000 WB Cell Signaling 
Ab, antibody; m, monoclonal; p, polyclonal; M, mouse; R, rabbit; GP, guinea pig; IF, 
immunofluorescence; IP, immunoprecipitation; WB, Western blot. 
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min. The pellet was washed once and the combined supernatants were centrifuged for 
20 min at 12 000 x g. The resulting crude membrane pellet was resuspended in buffer 
and the protein content was determined using either the Bradford (BioRad) or the BCA 
(Pierce) protein assay according to supplier’s instructions. For some radioligand binding 
experiments the homogenate was directly centrifuged for 20 min at 12 000 x g. The 
crude membranes were stored at -80°C until used. 
5.9 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western blotting 
Crude membranes or homogenates were thawed, supplemented with SDS-sample buffer 
(62.5 mM Tris pH 6.8, 10 % glycerol, 2.3 % SDS, 0.025 % bromphenolblue, 5 % 2-
mercaptoethanol) and heated for 5 min at 95°C. Samples were separated by SDS-PAGE 
according to Lämmli (1970). Following electrophoresis in 10 % mini gels (Mini Protean 
II, BioRad), proteins were transferred onto a nitrocellulose membrane (0.45 um, EGT 
Chemie) using a wet blotting device (BioRad) and 15 mM phosphate pH 6.8-7.5, 0.05 
% SDS and 20 % MeOH as transfer buffer. The transfer was performed at room 
temperature for one hour at 250 mA. The blotting efficiency was checked by reversible 
staining of proteins with 0.1 % amidoblack solution. Remaining protein binding sites on 
the nitrocellulose membrane were blocked with TBST containing 5 % non-fat milk 
powder (blocking solution) for at least one hour at room temperature. For 
immunodetection, the blots were incubated overnight at 4°C with the respective primary 
antibody diluted in blocking solution. The blots were washed once for 10 min with 
RIPEA (20 mM Tris pH 7.5, 60 mM NaCl, 2 mM EDTA, 0.4 % SDS, 0.4 % Triton X-
100, 0.4 % deoxycholate) and three times for 15 min with TBST (20 mM Tris pH 7.5, 
137 mM NaCl, 0.05 % Tween). Subsequently, the blots were incubated for one hour 
with the appropriate HRP-conjugated secondary antibody (1:5000, Jackson 
Immunoresearch) diluted in blocking solution. After washing the blots with RIPEA for 
10 min and three times for 15 min with TBST, immunoreactivity was detected by the 
enhanced chemoluminescence method (Pierce, Supersignal West Pico 
Chemiluminiscent Substrate) according to the supplier’s recommendations. 
Chemolumiscence was captured using a LAS-1000plus image analyzer (Fujifilm) and 
quantification of immunoreactive bands was performed with the AIDA software 
(version 3.25, Raytest, Germany). To ensure an analysis in the linear range, samples of 
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increasing protein concentrations were applied to SDS-PAGE and the blots were 
exposed for various times. 
5.10 Sucrose density gradient centrifugation 
For solubilization of GABAA receptors, crude membranes were thawed and washed 
once in 10 mM Tris pH 8, 150 mM NaCl, 1 mM EDTA, protease inhibitors (complete 
mini), and resuspended in the same buffer to give a protein concentration of 5 mg/ml. 
Following addition of sodium deoxycholate to a final concentration of 0.5 %, the 
mixture was incubated for 30 min on ice. Insoluble material was removed by 
centrifugation for 30 min at 100,000 x g. The supernatant was carefully removed and 
subjected to sucrose density centrifugation analysis. Linear sucrose gradients were 
prepared from 5 and 20 % sucrose in 50 mM Tris pH 8, 0.02 % NaN3, 0.5 % Triton X-
100. Deoxycholate extracts (600 μl) were layered on the top of each gradient (10 ml) 
and were centrifuged at 170 000 x g for 15 h at 4°C. After centrifugation, fractions of 
350 μl were collected and analyzed for α5, β2/3 or γ2 immunoreactivity by Western 
blotting as well as for [3H]Ro15-4513 and [3H]L655,708 binding (see below). 
Molecular size calibration was achieved using three marker proteins (4 mg/ml bovine 
serum albumine, aldolase and catalase) on gradients run in parallel. The presence of 
marker proteins in each fraction was determined by SDS-PAGE and staining with 
Coomassie brilliant-blue. 
5.11 Radioligand binding assays 
5.11.1 Receptor autoradiography 
The regional distribution of [3H]L655,708 and [3H]Ro15-4513 binding was analyzed on 
unfixed parasagittal cryostat-cut sections (12 μm) of adult wild type and α5(H105R) 
knock-in mouse brains. Slide-mounted sections were thawed and preincubated in 100 
mM Tris-HCl pH 7.4 for 15 min at 4°C, followed by incubation for 90 min with 20 nM 
of [3H]Ro15-4513 or 2 nM [3H]L655,708. Sections were washed three times for 15 s in 
buffer and finally dipped in distilled water. Subsequently, sections were dried and 
exposed to a tritium-sensitive phosphor screen (Packard Cyclone Storage Phosphor 
System, Packard, Meridian, CT) for 3-7 days. Nonspecific [3H]Ro15-4513 as well as 
[3H]L655,708 binding was assessed in parallel assays including 10 μM flumazenil. The 
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screens were scanned with a Packard Cyclone Scanner and labeling intensities were 
quantified using tritium standards (Microscale, Amersham) exposed in parallel.  
5.11.2 Saturation binding experiments 
For saturation binding experiments, crude mouse brain membranes were thawed and 
washed once with 50 mM Tris-HCl pH 7.4. Aliquots containing 100 μg protein were 
incubated with increasing concentrations (0.25, 0.5, 1, 1.5, 2, 3, 5, 7.5, 10, 12.5, 15, 20 
nM) of [3H]L655,708 (83 Ci/mmol, Amersham Biosciences) in a total volume of 0.2 ml 
for 90 min on ice. Nonspecific [3H]L655,708 binding was assessed at each radioligand 
concentration by inclusion of 10 μM flumazenil in the reaction. The incubation was 
stopped by rapid vacuum filtration on Whatman GF/C filters using a semiautomatic cell 
harvester (Skatron Instruments). Dried filters were subjected to liquid scintillation 
counting using 4 ml Ultima Gold as scintillation fluid. The binding data were analyzed 
using the program ‘KELL for Windows 6.0.5’ (Biosoft, UK). 
5.11.3 Competition binding assay 
For competition binding assays, mouse forebrain was homogenized and centrifuged at 
12000 x g. Aliquots of the resuspended pellet (300 μg protein/vial) were incubated in 
triplicates with 6 nM of [3H]Ro15-4513 and increasing concentrations of zolpidem (0, 
0.5, 1, 2.5, 5, 10, 25, 50, 100, 250, 500, 1 000, 2 500, 5 000, 10 000, 25 000, 50 000, 
100 000 nM). After 90 min of incubation on ice, the reaction mixtures were vacuum-
filtered through GF/C Whatman filters using a semiautomatic cell harvester (Skatron 
Instruments) and subjected to liquid scintillation counting. Nonspecific binding was 
determined in the presence of excess flumazenil (10 μM). Ligand binding data were 
analyzed using the program ‘KELL for Windows 6.0.5’ (Biosoft, UK).  
5.11.4 Ligand binding to immunoprecipitated GABAA receptors 
Membranes prepared from forebrains of wild type or α5(H105R) mice, were solubilized 
using 0.5 % deoxycholate (see above) and aliquots (1 ml) were incubated with 20 μl 
α1C, 20 μl α2C or 30 μl α3N antiserum, overnight at 4°C. Subsequently, 200 μl 
Pansorbin (suspension of 10 % Staphylococcus aureus; Calbiochem) was added and the 
mixture incubated 90 min at 4°C with constant rotation. After four times washing with 
solubilization buffer (10 mM Tris/HCl pH 8, 150 mM NaCl, protease inhibitors 
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(complete mini), 0.5 % deoxycholate) the precipitates were resuspended in the same 
buffer and probed in triplicates for [3H]Ro15-4513 (12 nM) and [3H]L655,708 (2 nM) 
binding (total reaction volume of 0.2 ml). After 90 min at 4°C, the samples were filtered 
through Whatman GF/C filters, which were pretreated with 0.1 % polyethyleneamine 
for 30 min at room temperature. Filtration was done using a manual filtration device 
(Milipore). The filters were rapidly washed three times with 4 ml ice-cold assay buffer 
(10 mM Tris-HCl pH 7.4, 150 mM NaCl) and subjected to scintillation counting. 
Nonspecific radioligand binding was determined by including 10 μM clonazepam in 
parallel incubations. 
Results  
6 Results 
GABAA receptors containing the α1, α2, α3 or α5 subunit mediate fast inhibitory 
neurotransmission that can be enhanced by allosteric modulation via the benzodiazepine 
binding site. Since they bind the benzodiazepine site agonist diazepam, these receptor 
subtypes are classified as diazepam-sensitive GABAA receptors. In contrast, receptors 
containing either the α4 or α6 subunit do not bind benzodiazepine site full agonists and 
thus constitute the class of diazepam-insensitive GABAA receptors. Diazepam-
sensitivity critically depends on a conserved histidine residue in the extracellular located 
N-terminal domain of the α subunits. This histidine residue is involved in formation of 
the benzodiazepam binding site at position 101 in α1 and in α2, 126 in α3 and 105 in 
α5 subunit. Mutation of the histidine residue to an arginine renders the respective 
receptor insensitive to diazepam binding. This point mutation was used to dissect the 
contribution of receptor subtypes containing distinct α subunits to the diverse actions of 
diazepam by generating α1(H101R), α2(H101R), α3(H126R) and α5(H105R) knock-in 
mouse lines (Rudolph et al. 1999, Löw et al. 2000, Crestani et al. 2002). In α5(H105R) 
mice, most actions of diazepam were similar to the wild type mice. However, 
α5(H105R) mice displayed changes in learning and memory performance caused by a 
selective reduction of α5 subunit protein in the hippocampus (Crestani et al. 2002). 
Since α5 mRNA levels were not reduced, the mutation seemed to influence 
posttranscriptional events in α5 subunit synthesis/degradation and/or receptor assembly. 
Our hypothesis was that the point mutation plays specific role in α5-GABAA receptor 
assembly or trafficking, issues that we aimed to analyze in HEK293 cells, cultured 
neurons and mouse brain tissue. 
The major experimental limitation we had to deal with was the lack of sufficient 
amounts of high-quality α5 subunit-selective antibodies. The high-quality antiserum 
available works exceptionally well in the immunocytochemical staining methods but 
would have been needed to be affinity-purified to work equally well for Western 
blotting. Since this antibody was raised in Guinea pigs, which results in only very small 
amounts of serum, affinity-purification of this precious antibody was prohibited. All 
attempts to generate a new suitable α5 subunit-selective antiserum failed so far. We 
tested dozens of bleedings from immunized Guinea pigs and rabbits for its suitability 
for Western blotting and immunoprecipitation and were not able to identify a single one. 
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In addition, the only commercial available α5 subunit-selective antibody (Abcam) 
yielded only very weak staining in Western blots and was therefore useless. 
These experimental constraints prevented a detailed Western blot analysis of the 
expression levels of the α5 subunit in different brain areas and on the subcellular level. 
All our attempts failed due to the limited sensitivity of the available antiserum in this 
assay. More importantly, we had no α5-selective antiserum for immunoprecipitation 
studies at our disposal, which prevented the direct isolation and analysis of the receptor 
population containing the α5 subunit.  
6.1 Expression level of  α5 subunits in wild type and α5(H105R) mouse brain  
α5-GABAA receptors display a particularly restricted distribution being most abundant 
in the hippocampus where they account for 22 ± 2 % of GABAA receptors (Sur et al. 
1998). Introduction of the H105R point mutation in the α5 subunit gene caused a 
reduction of α5 subunit protein expression by 20 ± 5 % in whole mouse brain (Crestani 
et al. 2002). As a first step in the biochemical analysis of α5(H105R)-GABAA receptors 
we determined the expression levels of α5 subunits in cortex/hippocampus preparations 
of α5(H105R) knock-in mice. Cortex/hippocampus tissue derived from 15 wild type 
and 15 α5(H105R) knock-in mice were divided into three pools of five animals each 
and were analyzed by Western blotting for α5 subunit expression. To ensure linearity of 
the signal, α5 subunit protein levels were measured at different protein concentrations 
and chemiluminiscence was captured using a highly light sensitive CCD camera (Fuji 
LAS 1000 imaging system) that enables measurements within a very broad dynamic 
range. At all protein concentrations tested, α5 subunit staining was considerably weaker 
in the hippocampus/cortex preparations of α5(H105R) knock-in mice than in wild type 
mice (Fig. 1A). Quantification of the Western blots revealed a 23 ± 2 % reduction of 
α5(H105R) expression (Fig. 1B). This result fits very well to the data published on 
whole mouse brain (20 ± 5 %, Crestani et al. 2002). 
41 
Results  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Expression level of α5 subunit in the forebrain of wild type and α5(H105R) 
knock-in mice. (A) Western blot of cortex/hippocampus preparations from wild type and 
α5(H105R) knock-in mice showed a reduction of the α5 subunit level at all protein 
concentration tested. β-actin levels were tested in parallel and served as controls for loading of 
equal amounts of protein. (B) Quantification of Western blot signals revealed a 23 ± 2 % 
reduction of α5(H105R) subunit expression. The signal intensity at 24 μg protein in wild type 
mice was set to 100%. The experiment was done three times using three pools of mice for each 
genotype (5 animals per pool). 
 
 
6.2 Expression and cell surface targeting of α5- and α5(H105R)-GABAA 
receptors in HEK293 cells 
To investigate potential causes for the observed reduction of α5(H105R)-GABAA 
receptors, we hypothesized that the α5(H105R) mutation might affect targeting of the 
receptor complex to the cell surface. This hypothesis was tested using GABAA receptors 
expressed in HEK293 cells, where defined subunit combinations can be expressed and 
their subcellular localization easily monitored. 
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To analyze whether the α5(H105R) mutation affects cell surface expression of the 
receptor complex, HEK293 cells were transiently transfected with plasmids coding for 
β3, γ2 and either α5 or α5(H105R) subunits. The cells expressing α5- or α5(H105R)-
GABAA receptors were fixed and permeabilized with Triton X-100 to label all α5 
subunits irrespective of their subcellular localization (Fig. 2, left panel). Alternatively, 
cells were not permeabilized to selectively detect α5 receptors on the cell surface (Fig. 
2, right panel). Both α5 and α5(H105R) subunits were abundantly found in intracellular 
compartments and at the plasma membrane. Visually inspected, the signal intensities for 
the wild type α5 subunit and the α5(H105R) subunit appeared similar, suggesting 
comparable levels of receptor expression within the cells and at the cell surface. 
 
 
 
 
 
 
 
 
 
 
 
 
                            
Figure 2. Immunofluorescence staining of the α5 subunit in HEK293 cells transiently 
transfected with the α5β3γ2 or α5(H105R)β3γ2 subunit combination. The cDNAs of α5 or 
α5(H105R) subunits combined with β3 and γ2 cDNAs were introduced into HEK293 cells via 
calcium phosphate transfection. After 48 hours of expression, cells were immunostained using 
α5 subunit-selective antibodies and visualized by confocal scanning microscopy. Cells 
permeabilized with Triton X-100 resulted in labeling of total α5 protein content (left panel). 
Staining of nonpermebilized cells (right panel) retained an intact plasma membrane and resulted 
in detection of cell surface receptors. Total expression as well as cell surface expression of α5 
and α5(H105R) receptors appeared similar. Scale bar: 10 μm. 
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In order to quantify total and cell surface expression of the receptors, HEK293 cells 
expressing the α5β3γ2 and α5(H105R)β3γ2 subunit combinations were subjected to 
enzyme-linked immunosorbent assay (ELISA). Transfected cells grown on 96-well 
plates were probed with α5 subunit-specific antibodies either in non-permeabilized cells 
for detection of cell surface receptors or in cells permeabilized with Triton X-100 for 
detection of total expression of receptors (cell surface and intracellular receptors). 
Bound α5 antibodies were detected via a colorimetric reaction and quantified using a 
microplate reader. The measurements revealed comparable signals for both α5 and 
α5(H105R) subunits with optical densities of 0.206 ± 0.071 and 0.204 ± 0.023, 
respectively (Tab. 1). This finding indicates similar transfection and expression levels of 
α5 and α5(H105R) subunits in HEK293 cells. The plasma membrane inserted α5 and 
α5(H105R) receptors were calculated as a percentage of total α5 and α5(H105R) 
subunits expressed and amounted to 60 ± 4 % for α5 receptors and 56 ± 5 % for 
α5(H105R) receptors in HEK293 cells (Tab. 1). 
These experiments indicate that - in contrast to neurons in situ - expression and cell 
surface targeting of α5(H105R) receptors appeared not to be affected in this cell type. 
 
 
Table 1. ELISA revealed similar plasma membrane insertion of both 
α5β3γ2 and α5(H105R)β3γ2 receptors in HEK293 cells. 
 
 
 
 
HEK293 cells expressing the α5β3γ2 or α5(H105R)β3γ2 subunit combinations were 
grown on 96-well plates and subjected to ELISA. Cells were fixed with PFA and either 
nonpermeabilized for detection of cell surface receptors or permeabilized with Triton 
X-100 for determination of total expression of receptors (cell surface and intracellular 
receptors). After labeling with α5 subunit-specific antibodies, cells were incubated with 
HRP-conjugated secondary antibodies. HRP activity was detected via a colorimetric 
reaction using TMB as substrate and quantified using a microplate reader. Nonspecific 
staining was determined in parallel cultures of nontransfected cells. The results are 
given as mean ± SD from four independent experiments. 
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6.3 Targeting of α1β2γ2 and α5β3γ2 GABAA receptors in cultured neurons 
The expression levels and targeting to the cell surface of α5- and α5(H105R)-GABAA 
receptors in HEK293 cells were found to be essentially indistinguishable and suggests 
that the assembly and trafficking of receptor complexes in these cells is unaffected by 
the point mutation. This finding is in striking contrast to the reduced expression levels 
of α5(H105R)-GABAA receptors observed in brain. This apparent discrepancy might be 
due to overexpression of α5-receptors in HEK293 cells, which may override subtle 
effects of the point mutation on either targeting efficiency and/or turnover of 
α5(H105R)-GABAA receptors. Therefore, we aimed at analyzing trafficking of α5 
receptors within neurons using novel tagging techniques for receptor visualization and 
tracking in living cells. Both, the biarsenical-tetracysteine labeling and α-bungarotoxin 
labeling techniques have been reported to be applicable on living neurons (Ju et al. 
2004, Sekine-Aizawa and Huganir 2004) and were expected to be powerful tools to 
investigate α5 and α5(H105R) receptors trafficking. 
6.4 Biarsenical-tetracysteine labeling of α1TetraCysβ2γ2 receptors in HEK293 
cells and cultured neurons 
To investigate the trafficking of α5-GABAA receptors, we first aimed at establishing the 
non-invasive biarsenical-tetracysteine labeling method (Zhang et al. 2002, Ju et al. 
2004). This method allows the site-specific labeling of a protein upon introduction of a 
small tetracysteine tag CCPGCC, which is recognized by membrane-permeable red 
(Lumio red) or green (Lumio green) fluorescent biarsenical dyes (Zhang et al. 2002). 
These organic dyes are designed to become fluorescent upon covalent binding to the 
sulphur atoms of the cysteines in the tag. The most important feature is that this kind of 
labeling can be conducted in living cells where the tagged protein can be visualized and 
tracked during a time course of hours. In addition, this method permits pulse-chase 
experiments, which are required for the intended study on the trafficking of GABAA 
receptors. 
As a model system to test the labeling method, we used the α1-GABAA receptor 
subtype transiently expressed in HEK293 cells. Since the binding of biarsenical 
flourophores requires reducing conditions present in the cytoplasm, the tetracysteine tag 
(CCPGCC) was cloned into the large intracellular loop of the α1 subunit (amino acid 
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383) and subsequently the specificity of Lumio red and Lumio green dyes for the 
inserted tag was tested. To avoid toxicity and binding of the trivalent arsenic atoms to 
endogenous thiols, micromolar concentrations of the antidote 1,2-ethanedithiol (EDT2) 
were included in the labeling solution. Double immunofluorescence staining on 
HEK293 cells expressing the α1(TetraCys)β2γ2 combination was performed using the 
biarsenical fluorophores and an antibody selectively recognizing the α1 subunit. The α1 
subunit-selective antibody served as a control for the specificity of the Lumio staining. 
Although we observed high background staining with Lumio green, in many HEK293 
cells expressing α1(TetraCys)β2γ2 the labeling matched very well the α1 antibody 
staining at the cell surface and at intracellular sites (Fig. 3). However, also non-
transfected HEK293 cells exhibited considerable staining with Lumio green (not 
shown). In contrast, the second fluorophore Lumio red showed no colocalization with 
α1 antibody labeled receptors and was nonspecifically distributed throughout the cells 
(Fig. 3). All efforts to optimize the labeling conditions and to reduce background 
labeling, including labeling time, EDT2 concentration, Lumio dye concentrations and 
washing conditions, did not result in any improvement of specific labeling. Therefore, 
this, at first sight, very promising labeling method could not be used for the planned 
studies on the trafficking of α5-GABAA receptors, which required pulse-chase 
experiments. 
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Figure 3. Specificity of Lumio green and Lumio red biarsenical dyes tested on HEK293 
cells expressing α1(TetraCys)β2γ2 GABAA receptors. Live cells expressing the 
α1(TetraCys)β2γ2 combination were labeled with Lumio green (1 μM) or Lumio red (2.5 μM), 
which bind to the TetraCys tag within the α1 subunit. Immunoflourescence staining with α1 
specific antibodies was used to test for the specificity of Lumio dye labeling. (A) 
Nonpermeabilized cells as well as permeabilized cells (B) showed a good colocalization of 
Lumio green (green) and α1 antibody staining (red). On the contrary, no colocalization of α1 
staining (green) has been achieved with Lumio red in either nonpermeabilized (C) or in 
permeabilized cells (D). In all cases a high background level was encountered. Scale bar 10 μm. 
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Since different cell types may yield distinct levels of background labeling and because 
the efficient labeling of tagged AMPA receptors transiently expressed in neurons with 
biarsenical dyes has been reported (Ju et al. 2004), we next tried to apply this method to 
transfected primary cultured cortical neurons. In order to discriminate transfected 
α1TetraCys subunits from the endogenous α1 subunits present in neurons, we added a 
myc-tag or a flag-tag at the C-terminus of the α1TetraCys subunit. Transfection of the 
engineered α1 subunit into cultured neurons was achieved with nucleofection. Since 
this transfection method requires a sustained expression of the vector protein over a 
period of one to three weeks, the α1TetraCys-myc or α1TetraCys-flag constructs were 
subcloned into the appropriate expression vector pβAct. The pβAct vector contains the 
chicken β-actin promoter and enables moderate and sustained protein expression, but 
yielded rather low transfection efficiencies (less than 1%). The specificity of Lumio 
dyes was tested by immunoflourescence staining of nontransfected neurons and neurons 
transfected with the α1TetraCys-myc or the α1TetraCys-flag construct. Live 
nontransfected neurons were incubated with Lumio dyes, fixed and stained with α1 
antibody that binds to endogenously expressed α1 subunits. Unfortunately, both Lumio 
dyes caused high background levels as well as significant cytotoxicity, as indicated by a 
vacuolized cell soma (Fig. 4). 
Furthermore, transfected neurons were also labeled with Lumio dyes, fixed and probed 
for the presence of transfected and endogenous α1 subunits using antibodies that 
recognize the myc-tag, flag-tag or α1 subunit. As in nontransfected neurons, both 
Lumio green and Lumio red dyes exhibited considerable nonspecific staining in neurons 
(Fig. 5). Neurons had severely vacuolized soma and the Lumio dyes did not specifically 
colocalize with myc, flag or α1 antibody signals. All attempts to reduce the background 
staining to a manageable level failed. Therefore this labeling method could not be used 
for the intended experiments. 
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Figure 4. Lumio green and Lumio red biarsenical dyes tested on nontransfected cultured 
cortical neurons demonstrate severe background levels. Living neuronal cells (DIV21) were 
labeled with Lumio green (1 μM) or Lumio red (2.5 μM) and, upon fixation with PFA and 
permeabilization with Triton Tx-100, immunostained with α1 specific antibodies. (A) Lumio 
green and (B) Lumio red labeled nonspecifically neurons. Control staining for the α1 subunit, 
mostly found in the plasma membrane, (A in red, B in green) showed that Lumio dyes 
accumulated in the soma. Scale bar: 10 μm. 
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Figure 5. Specificity of Lumio dyes tested on cortical neurons expressing α1TetraCys-myc 
or α1TetraCys-flag constructs. Neurons were transfected using the nucleofection method with 
the α1TetraCys subunit tagged with the myc or flag epitope to enable the distinction between 
transfected and endogenous α1 subunits. Live cells (DIV8) were labeled with Lumio red (2.5 
μM) or Lumio green (1 μM), fixed with PFA, permeabilized with Triton X-100 and 
immunostained using α1 and myc or flag antibodies. (A) Labeling of the α1TetraCys-myc 
tagged subunit with myc antibodies (green), Lumio red (red) and α1 antibodies (blue). (B) 
Labeling of the α1TetraCys-flag subunit with flag antibodies (red), Lumio green (green) and α1 
antibodies (blue). Myc and flag antibodies selectively stained the TetraCys tagged α1 subunit, 
whereas the α1 antibody detected both the transfected and endogenous α1 subunit. In both 
cases, Lumio staining did not colocalize with myc or flag antibody staining and therefore 
exhibited exclusively non-specific staining. Scale bar: 10 μm. 
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6.5 Imaging of GABAA receptors in HEK293 cells and cultured cortical 
neurons using α-bungarotoxin binding site-tagged α5 subunits 
To circumvent the problem of high background staining with Lumio dyes we aimed for 
another promising approach to monitor GABAA receptor trafficking within living cells. 
This new labeling method is based on the introduction of the minimal α-bungarotoxin 
binding site into the N-terminal domain of the α5 subunit. α-Bungarotoxin is a high-
affinity ligand for the nicotinic acetylcholine receptor and binds to the short amino acid 
sequence WRYYESSLEPYPD in a virtually irreversible manner (Harel et al. 2001). It 
is available in a fluorescent, biotinylated and radioactive form, which enables a large 
variety of quantitative and qualitative analyses of the tagged protein, including pulse-
chase experiments. In addition, this labeling method has been successfully applied on 
transfected neurons (Sekine-Aizawa and Huganir 2004). 
The α-bungarotoxin tag (btx) was introduced into the extracellular domain of the α5 
subunit (amino acid 36) to permit the selective labeling of cell-surface receptors and 
analysis of receptor membrane insertion as well as receptor internalization. The labeling 
method was first established on HEK293 cells expressing α5btxβ3γ2 receptors. Living 
cells were treated with AlexaFlour488-conjugated α-bungarotoxin to label the α5btx 
subunit. After fixation, the specificity of α-bungarotoxin labeling was tested using 
immunostaining with α5 and β2/3 specific antibodies. In HEK293 cells excellent 
colocalization of AlexaFlour488-α-bungarotoxin and α5 antibody signals was found 
(Fig. 6). On nontransfected HEK293 cells, AlexaFlour488-α-bungarotoxin showed 
virtually no background staining. Since the specificity of AlexaFlour488-α-
bungarotoxin labeling of α5btx subunit was confirmed, we focused on establishing this 
method in neurons to study the trafficking of α5-GABAA receptors. 
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Figure 6. AlexaFlour488-α-bungarotoxin labeling of α5btxβ3γ2 receptors expressed in 
HEK293 cells. AlexaFlour488-α-bungarotoxin labeling of the α5btx subunit was performed on 
living cells, which were subsequently fixed and double immunostained using α5 and β2/3 
specific antibodies. (A) Nonpermeabilized cells showed colocalization (white) of α5 (red) and 
β3 (blue) immunostaining with AlexaFlour488-α-bungarotoxin labeling of the α5btx subunit 
(green) at the cell surface. (B) Permeabilized cells revealed in addition low levels of 
intracellular staining. Scale bar:10 μm. 
52 
 Results 
 
After successful application of the α-bungarotoxin labeling method on α5btxβ3γ2 
receptor expressing HEK293 cells, we applied this technique on cultured neurons 
transfected with the α5btx subunit construct. Cortical neurons (DIV 4) were transfected 
using the NeuroFect agent, which - in our hands - exhibited higher transfection 
efficiency than the nucleofection method. After 24 hours of expression, neurons were 
briefly incubated with tubocurarine to block endogenous α-bungarotoxin binding sites 
present on α7 nicotinic acetylcholine receptors. Subsequently, nontransfected neurons 
and neurons transfected with the α5btx construct were both labeled with 
AlexaFlour488-α-bungarotoxin to determine nonspecific and specific labeling signals, 
respectively. As a control, neurons were immunostained for the presence of α5 subunits. 
Unfortunately, the AlexaFlour488-α-bungarotoxin labeling did not colocalize with the 
α5 antibody staining in transfected neurons (Fig. 7). Moreover, the transfected and 
nontransfected cortical neurons were essentially indistinguishable and showed high 
background levels upon labeling with AlexaFlour488-α-bungarotoxin.  
In contrast to HEK293 cells, AlexaFlour488-α-bungarotoxin displayed considerable 
non-specific staining in neurons, even after blocking endogenous α-bungarotoxin 
binding sites with tubocurarine. Therefore, this labeling method was not suitable for our 
intended studies on trafficking of α5(H105R) receptors in neurons. 
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Figure 7. Specificity of α-bungarotoxin labeling tested on nontransfected and on α5btx 
transfected cultured cortical neurons. After preincubation with tubocurarin, live cortical 
neurons (DIV 5) were labeled with AlexaFlour488-α-bungarotoxin (green), fixed and 
immunostained with α5 antibody (red). (A) Nontransfected neurons showed significant 
background when stained with AlexaFlour488-α-bungarotoxin. (B) Neurons transfected with 
the α5btx construct using the NeuroFect reagent, were also nonspecifically labeled with 
AlexaFlour488-α-bungarotoxin. Scale bar: 10 μm. 
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6.6 Expression and targeting of α5 and α5(H105R)-GFP-tagged subunits in 
primary cortical neurons 
The approaches of labeling tetracysteine or α-bungarotoxin tagged α5 subunits with 
Lumio dyes and AlexaFlour488-α-bungarotoxin conjugate, respectively, were not 
suitable for monitoring trafficking of the receptors in neurons due to high nonspecific 
labeling. Therefore, we used the well established GFP tag to label the α5 subunit, which 
was expected to answer the question to what extent α5(H105R) subunits are expressed 
in neurons and targeted into dendrites. 
The GFP tag was inserted at the C-terminus of the wild type α5 subunit and 
subsequently the H105R mutation was introduced by site directed mutagenesis. Using 
NeuroFect, cultured cortical neurons were transfected with plasmids containing either 
the α5-GFP or the α5(H105R)-GFP construct. After 24 hours, the neurons were fixed 
and probed for α5- and GFP-immunoreactivity (Fig. 8). The GFP tag enabled 
immediate detection of the transfected α5 subunit protein, while GFP and α5 subunit 
antibodies were used to confirm the specificity of the signals. Analysis by confocal 
scanning microscopy showed that the GFP-tagged α5 and α5(H105R) subunits were 
expressed to similar levels in the soma of neurons and were both targeted into proximal 
and distal dendrites. The GFP fluorescence colocalized with GFP and α5 subunit 
antibody staining, documenting the specificity of the signals. Since no appreciable 
difference in expression and targeting was observed, these processes did not seem to be 
significantly influenced by the H105R mutation upon over-expression in neurons.  
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Figure 8.  Expression and targeting of GFP-tagged α5 and α5(H105R) subunit in cultured 
cortical neurons. Cortical neurons (DIV5) were transfected with the α5-GFP or α5(H105R)-
GFP construct using NeuroFect and analyzed 24 h later. Cells were fixed, permeabilized and 
double immunostained using α5 (blue) and GFP (red) specific antibodies, which showed 
colocalization (white) with the GFP signal (green). The α5 antibody staining has detected 
endogenous α5 subunits as well. No apparent differences in expression and targeting between 
(A) α5-GFP and (B) α5(H105R)-GFP subunits were observed. Scale bar: 10 μm. 
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6.7 Determination of benzodiazepine binding sites in the hippocampus of 
α5(H105R) mice using receptor autoradiography 
The results accumulated so far indicated that although the H105 mutation caused a 
moderate decline in α5 subunit protein levels in situ, the expression and targeting of 
α5(H105R) subunits appeared to be unchanged after overexpression in HEK293 cells as 
well as in cultured neurons. However, the limitation of antibody-based methods to 
analyze heterooligomeric proteins is that total subunit protein levels are monitored, 
irrespective of whether they are assembled into functional protein complexes or not. 
Since binding of ligands to the benzodiazepine site requires fully assembled GABAA 
receptors, radioligand binding provides a means to analyze for the presence of 
assembled receptor complexes. To determine the levels of assembled α5-GABAA 
receptors in brain tissue of wild type and α5(H105R) mice, two radioligands interacting 
with the benzodiazepine site were used: [3H]Ro15-4513, which binds to all GABAA 
receptor subtypes containing an α subnit and the γ2 subunit (Benke et al. 1996) and 
[3H]L655,708, which interacts with high affinity selectively with the α5-GABAA 
receptor subtype (Quirk et al. 1996, Casula et al. 2001). 
To achieve a high spatial resolution, parasagittal brain sections were probed for 
[3H]Ro15-4513 binding using a saturating concentration of radioligand. When inspected 
visually, autoradiograms of brain sections of wild type and α5(H105R) knock-in mice 
appeared to display similar [3H]Ro15-4513 binding levels (Fig. 9). However, 
quantification of [3H]Ro15-4513 binding to the whole hippocampal formation revealed 
a 7 ± 0.5 % (n = 9, P < 0.02, two-tailed t-test) reduction of [3H]Ro15-4513 binding in 
α5(H105R) mice, which is attributed to the deficit of α5-GABAA receptors in the 
mutants. Since in the hippocampus of wild type mice α5-GABAA receptors account for 
22 ± 2 % of GABAA receptors (Sur et al. 1998), this finding implies an about 30-40% 
reduction of α5(H105R)-GABAA receptors. A detailed quantification of [3H]Ro15-4513 
binding levels in individual regions of the hippocampal formation revealed a non-
uniform 8-18 % reduction of binding, depending on the subregion (Tab. 2). The most 
prominent reduction in [3H]Ro15-4513 binding was detected in CA1 stratum oriens, 
CA1 stratum lacunosum, CA3 stratum radiale and dentate gyrus granule cell layer (Tab. 
2). 
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In order to directly quantify α5-GABAA receptor levels on parasagittal brain sections, 
we used the α5 subtype-specific radioligand [3H]L655,708, which displays a 100-fold 
higher affinity for α5-GABAA receptors than for other GABAA receptor subtypes. Most 
strikingly, a strong reduction of [3H]L655,708 binding was observed in all brain areas 
expressing the α5 subunit (Fig. 9). Quantification of [3H]L655,708 binding levels 
revealed a reduction of 39 ± 4 % in the olfactory bulb (P < 0.0001), 47 ± 5% in the 
hippocampal formation (P < 0.0001), 43 ± 0.4 % in the superior colliculus (P < 0.0001) 
and 53 ± 6 % in the motor cortex (P < 0.0001, two-tailed t-test, n= 6 mice, 3 sections 
per mouse). These findings indicate that the strong reduction of α5-GABAA receptors in 
α5(H105R) mice is not limited to hippocampus, but it is common to all brain regions 
expressing the α5-GABAA receptor subtype. 
As for [3H]Ro15-4513 binding levels, a detailed quantification revealed a non-uniform 
reduction (18-66 %) of [3H]L655,708 binding among hippocampal subregions, with the 
highest reduction in CA1 stratum oriens, CA1 stratum pyramidale, and dentate gyrus 
granule cell layer (Tab. 2).  
The reduction of [3H]Ro15-4513 binding in the hippocampal subregions analyzed 
largely corresponded to that observed for [3H]L655,708 binding. However, differences 
in the degree of reduction were found in the CA1 stratum pyramidale and in the hilus of 
the dentate gyrus, where a reduction of [3H]Ro15-4513 binding was not clearly detected 
or moderate, respectively, whereas the [3H]L655,708 binding was strongly decreased. 
At present the cause for these mismatches is unknown. Other minor inconsistencies are 
apparently due to variations in labeling intensities among sections, which is reflected by 
the partly large standard deviation observed for [3H]Ro15-4513 binding.  
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Figure 9. Autoradiographic distribution of [3H]Ro15-4513 and [3H]L-655,708 binding sites 
in parasagittal brain sections of wild type and α5(H105R) mice. Top panel: Labeling of 
diazepam-sensitive and diazepam-insensitive GABAA receptors with [3H]Ro15-4513 (20 nM) in 
12 μm parasagittal brain slices of wild type and α5(H105R) mice. Quantification of [3H]Ro15-
4513 binding in hippocampus revealed a 7 ± 0.5 % (n = 9, P< 0.02, two-tailed t-test) reduction 
of binding in α5(H105R) mice. Bottom panel: Labeling of α5-GABAA receptors using the α5-
specific ligand [3H]L655,708 (1 nM). Binding levels were strongly reduced in all brain areas 
expressing the α5 subunit of α5(H105R) mice. Quantification of [3H]L655,708 binding in 
hippocampus revealed a 47 ± 5 % (n=6) reduction of binding in α5(H105R) mice. Nonspecific 
binding was assessed in the presence of 10 μM flumazenil and resulted in virtually no 
background staining at the exposure times used (not shown). 
 
Table 2. Quantification of [3H]Ro15-4513 and [3H]L-655,708 binding in the hippocampal 
formation of wild type and α5(H105R) mice.  
 
Radioligand binding was performed on fresh-frozen brain sections derived from 3 mice per 
genotype (3 sections per animal) for [3H]Ro15-4513 binding and 6 mice per genotype (3 
sections per animal) for [3H]L655,708 binding. Images were acquired using a high resolution 
phosphoimaging system and signals were quantified using the OptiQuant software. Nonspecific 
binding was assessed using excess flumazenil. Values are expressed as mean ± SD (n=6). Data 
evaluated using two-tailed t-test. Abbreviations: s. or, stratum oriens; s. pyr, stratum 
pyramidale; s. rad, stratum radiale; s. lm, stratum lacunosum-moleculare; DG, dentate gyrus; s. 
mol, stratum moleculare; NS, non significant (P > 0.05). 
59 
Results  
6.8 Affinity and abundance [3H]L655,708 binding sites in wild type and 
α5(H105R) knock-in mice  
The receptor autoradiography revealed a strong reduction of high affinity [3H]L655,708 
binding to α5-GABAA receptors in the brain of α5(H105R) knock-in mice. Unlike 
[3H]Ro15-4513, which was used at saturating concentrations (5-6 fold of KD-value), 
[3H]L655,708 could only be used at near-saturating concentrations (2 fold of KD-value) 
since at higher ligand concentrations there is a risk of labeling also other GABAA 
receptor subtypes. Therefore, moderate changes in the affinity to [3H]L655,708 
potentially caused by the H105R mutation in the α5(H105R) receptors could result in 
the observed reduction in [3H]L655,708 binding. To rule out any effect of the H105R 
mutation on the affinity of [3H]L655,708, saturation binding experiments were 
performed to determine the affinity (KD value) and number of binding sites (Bmax value) 
of [3H]L655,708 for wild type and mutant α5-receptors. Saturation binding experiments 
were done on crude membranes prepared from brains of wild type and α5(H105R) mice 
using increasing concentrations of [3H]L655,708. As expected, the binding data fitted 
best to a model of two binding sites for [3H]L655,708 (Fig. 10): a high affinity binding 
site corresponding to α5-receptors and a low affinity binding site corresponding to other 
receptor subtypes (Quirk et al. 1996). Analysis of the high affinity component revealed 
a 76 ± 10% reduction (n=4, P < 0.0001, two tailed t-test) of binding sites for 
[3H]L655,708 in α5(H105R) mice (Bmax1 = 9 ± 3 fmol/mg protein) as compared to wild 
type mice (Bmax1 = 39 ± 6 fmol/mg protein) with no change of the affinity (KD1 
α5(H105R): 0.6 ± 0.2 nM, KD1 wild type 0.5 ± 0.1 nM).  In contrast, KD and Bmax values 
of the low affinity binding component were similar in both genotypes (α5(H105R): KD2 
= 44 ± 6 nM and Bmax2 = 505 ± 190 fmol/mg, wild type: KD2 = 58 ± 3 nM and Bmax2 = 
448 ± 193 fmol/mg). These results demonstrate that the number of binding sites and not 
the affinity of α5(H105R)-GABAA receptor for [3H]L655,708 is affected by the 
α5(H105R) mutation. 
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Figure 10. Scatchard representation of [3H]L655,708 saturation binding data to wild type 
and α5(H105R) brain membrane preparations. The binding of [3H]L655,708 displays two 
components: the high affinity site represents binding to α5-GABAA receptors and low affinity 
site represents binding to other GABAA receptor subtypes. The high affinity component is 
characterized in wild type mice by KD1 = 0.5 ± 0.1 nM and Bmax1 = 39 ± 6 fmol/mg protein. In 
α5(H105R) mice the KD was unchanged (KD1 = 0.6 ± 0.2 nM) but the number of binding sites 
was strongly reduced (Bmax1 = 9 ± 3 fmol/mg protein). The low affinity components were 
similar in both genotypes (wild type: KD2 = 58 ± 3 nM, Bmax2 = 448 ± 193 fmol/mg protein; 
α5(H105R): KD2 = 44 ± 6 nM, Bmax2 = 505 ± 190 fmol/mg protein). The results shown are 
representative for three independent experiments. 
 
 
 
6.9 Analysis of the amount of assembled α5(H105R)-GABAA receptors 
The saturation binding experiments revealed a strong reduction (76%) of high affinity 
binding sites for [3H]L655,708, corresponding to α5-GABAA receptors in α5(H105R) 
mice. However, this finding did not correspond to the moderate 23 ± 2% reduction of 
the α5(H105R) subunit protein. Thus, we hypothesized that α5 subunits containing the 
H105R mutation may not efficiently assemble into functional, i. e. ligand binding 
receptor complexes. In order to separate potential unassembled α5 subunits from 
assembled α5-receptor complexes, we performed sucrose density gradient analyses on 
brain extracts of α1(H101R) and α5(H105R) mice. Brain extracts of α1(H101R) mice 
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served as a control, since the analogues mutation in the α1 subunit did not influence the 
expression levels of this GABAA receptor subtype (Rudolph et al. 1999). Brain 
membrane proteins of both genotypes were solubilized and subsequently separated 
according to their molecular sizes on continuous 5-20 % sucrose density gradients. 
After centrifugation, the gradients were fractioned and individual fractions were 
analyzed for the presence of α5, α1, β2/3 and γ2 subunits by Western blotting (Fig. 11 
A, B). In α1(H101R) mice the α1-, α5-, β2/3- and γ2-signals were detected in the high 
molecular fractions, indicating that the entire population of GABAA receptor subunits 
assembled into macromolecular receptor complexes. Likewise, in α5(H105R) mice, all 
subunits were detected as well in the high molecular fractions, also indicating the 
presence of assembled α5(H105R)-GABAA receptors. No evidence for appreciable 
amounts of monomeric, non-assembled α5 subunits was found. The signal intensity of 
α5 subunits on the Western blots derived from gradients of α5(H105R) mice was found 
to be lower than the staining intensity of α5 subunits in the blots derived from gradients 
of α1(H101R) mice (Fig. 11 A, B), being in line with the reduced expression levels of 
α5(H105R) subunits. 
The gradient fractions were also probed for their ability to bind [3H]Ro15-4513 and 
[3H]L655,708. As expected, a peak of binding for both radioligands was detected in the 
high molecular weight fractions of both genotypes. However, whereas both genotypes 
displayed almost identical binding profiles for [3H]Ro15-4513 (Fig. 9 C), [3H]L655,708 
binding was strongly reduced (60 ± 6.6 %, n=3) in gradients derived from α5(H105R) 
mice (Fig. 11 D). These results indicate that α5 subunits containing the H105R mutation 
assemble into high molecular complexes and display strongly reduced [3H]L655,708 
binding. 
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Figure 11. Sucrose density gradient centrifugation of native GABAA receptors from brains of 
α1(H101R) and α5(H105R) mice. Deoxycholate extracts of mouse brain membranes were 
separated according to their molecular size on 5-20 % linear sucrose gradient by centrifugation at 
170 000 x g for 15 h at 4°C. (A, B) After centrifugation, individual fractions were analyzed for α1, 
α5, β2/3 or γ2 subunit immunoreactivity by Western blotting. (A) Western blots of gradient fractions 
derived from brain membrane extracts of α1(H101R) mice, which were used as a control. (B) 
Western blots of gradient fractions derived from brain membrane extracts of α5(H101R) mice. In 
both genotypes, all subunits were exclusively detected in the high molecular fractions, indicating 
assembled GABAA receptor complexes. The α5(H105R) subunit was found  to be less abundant than 
the α5 subunit in α1(H101R) mice as judged by their signal intensities. Molecular size calibration 
was achieved using marker proteins (bovine serum albumine, aldolase and catalase) run in parallel 
gradients. (C, D) Determination of [3H]Ro15-4513 (12 nM) and [3H]L655,708 (2 nM) binding 
present in the fractions of the gradients containing α1(H101R) and α5(H105R) brain extracts. The 
data shown are representative for three independent experiments. 
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6.10 Pharmacological separation of GABAA receptor subtypes in wild type and 
α5(H105R) knock-in mice 
So far, the severe loss in α5(H105R) mice of high affinity [3H]L655,708 binding sites 
cannot be explained by a fundamentally impaired assembly or targeting of α5 receptors. 
We neither observed the accumulation of an intracellular pool of unassembled 
α5(H105R) subunits in brain tissue nor an impaired expression and cell surface 
targeting after over-expression of α5(H105R) subunits in either HEK293 cells or 
primary cultured neurons. However, more subtle alterations may occur that resulted in 
the observed loss of α5-selective binding. In this respect, the existence of GABAA 
receptors containing two different types of α subunits in a single receptor complex has 
been well documented (Araujo et al. 1999, Del Rio et al. 2001, Benke et al. 2004). In 
such receptor complexes, the benzodiazepine site binding properties is expected to 
depend on the positioning of the distinct α subunits within the complex since the 
interface of α and γ2 subunits forms the binding site (reviewed by Siegel 2002). Thus, 
only the type of α subunit positioned next to the γ2 subunit is expected to contribute to 
the benzodiazepine site and would determine its drug binding properties. In line with 
this hypothesis, in receptors containing the α1 and α5 subunit, the α5 subunit was 
found to be pharmacologically dominant over the α1 subunit and consequently the 
receptor displayed α5 pharmacology (Araujo et al. 1999). The predominance of α5-
pharmacology implicates that during assembly of the receptor complex the α5 subunit is 
favorably arranged next to the γ2 subunit. Therefore, we hypothesized that the 
introduction of the H105R mutation into the α5 subunit might influence the 
arrangement of the α5 subunit within α1α5(H105R)-GABAA receptors. If in such 
receptor complexes the α1 subunit would preferentially be located next to the γ2 
subunit, this would provide an explanation for the loss of α5-specific [3H]L655,708 
binding sites. 
We aimed to test this hypothesis using radioligand competition experiments with the 
ligands [3H]Ro15-4513 and zolpidem as displacing agent. Zolpidem discriminates by 
affinity major GABAA receptor subtypes. It displays high affinity (10-20 nM) for 
receptors containing the α1 subunit, intermediate affinity for α2- and α3- containing 
receptors (200-300 nM) and low affinity for α5-containing receptors (6->10 μM) 
(Ruano et al. 1992, Benavides et al. 1993, Quirk et al. 1996). The presence and 
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abundance of zolpidem binding sites in brain tissue of wild type and α5(H105R) mice 
was determined by competing the binding of [3H]Ro15-4513 ligand with increasing 
concentrations of zolpidem (0.5 nM to 100 μM). As expected, the binding data fitted 
best to a model consisting of three distinct binding sites for zolpidem in both genotypes 
(Fig. 12). No apparent change in the affinity and abundance of the high (α1-receptors) 
and medium (α2- and α3-receptors) affinity sites for zolpidem was detected in 
α5(H105R) knock-in mice (Tab. 3, 4). However, the affinity of the low affinity binding 
site corresponding to α5-receptors was slightly decreased (wild type: 33 ± 9 μM, 
α5(H105R): 101 ± 32 μM, Tab. 3). This decrease in affinity was expected since the 
α5(H105R) mutation renders the α5 receptors largely insensitive to benzodiazepine full 
agonists (Benson et al. 1998). Furthermore, the number of low affinity, i. e. α5-
receptor, binding sites was considerably lower (37%) in α5(H105R) mice (Bmax3 = 264 
± 42 fmol/mg protein) than in wild type mice (Bmax3 = 403 ± 69 fmol/mg protein, Tab. 
3). Likewise, when the relative Bmax3 values within each genotype were calculated, we 
detected 12 % low affinity zolpidem sites in wild type and 8 % in α5(H105R) mice 
(Tab. 4, P < 0.001, two-tailed t-test). In this case, the relative abundance of receptors 
with α5 pharmacology in α5(H105R) mice would be reduced by 44 % as compared to 
the wild type mice. 
A decrease in the number of low affinity zolpidem sites might be expected to be 
accompanied by an increase in high and/or medium affinity site if the H105R mutation 
indeed abolishes the potential predominant position of the α5 subunit next to the γ2 
subunit. In all three experiments performed we observed a small increase in the relative 
abundance of high affinity zolpidem binding sites corresponding to the α1-subunit 
pharmacology (Tab. 4). Unfortunately, this small increase in high affinity zolpidem sites 
was masked by the variation among experiments. This was not surprising given the 
small population of α5-GABAA receptors containing two distinct types of α subunits. 
Nevertheless, the reduction of low affinity zolpidem binding sites and the concomitant 
increase in high affinity binding sites that was observed in each individual experiment 
suggests a change in the positioning of α subunits within GABAA receptors containing 
two distinct α subunits. 
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Figure 12. Zolpidem competition of [3H]Ro15-4513 binding in wild type and α5(H105R) 
forebrain preparations revealed a reduced number of zolpidem-insensitive binding sites in 
α5(H105R) mice. Binding of [3H]Ro15-4513 (6 nM) to forebrain preparations of wild type and 
α5(H105R) mice was displaced using increasing concentrations of zolpidem (0.5 nM to 100 
μM). The number of high and medium affinity zolpidem binding sites was comparable in both 
genotypes. The relative number of zolpidem-insensitive binding sites in α5(H105R) mice was 
44 % reduced as compared to wild type mice. Nonspecific binding was determined in presence 
of 10 μM flumazenil. Data represent the mean ± SD of three independent experiments. Standard 
deviations are not visible if smaller than the depicted circles. Ligand binding data were 
analyzed using the program ‘KELL for Windows 6.0.5’ (Biosoft, UK) and depicted in 
tables 3 and 4. 
 
 
Table 3. Zolpidem binding to GABAA receptor subtypes in the forebrain of α5 wild type 
and α5(H105R) mice.  
 
Values are means ± SD of three independent experiments and were derived form the 
competition experiments shown in Fig. 12. 
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Table 4. Relative abundance of zolpidem binding components in α5 wild type and 
α5(H105R).  
 
mice. 
Values are means ± SD of three independent experiments and were derived form the 
competition experiments shown in Fig. 12. Bmax3 is significantly lower in the α5(H105R) mice 
(P < 0.002, two-tailed t-test). 
 
 
 
6.11 Influence of the H105R mutation on the pharmacological dominance of the 
α5 subunit in α5-GABAA receptors containing two distinct types of α 
subunits 
The zolpidem competition experiments were unfortunately not sensitive enough to 
provide clear evidence for the hypothesis that the H105R mutation may affect the 
positioning of the α5 subunit in GABAA receptors containing two distinct types of α 
subunits. To overcome this problem, we intended to immunoprecipitate the α5-GABAA 
receptor subtypes for a further analysis. However, one major shortcoming was the lack 
of sufficient amounts of α5 subunit-selective antibodies suitable for 
immunoprecipitation of α5-receptors.  
Since we could not directly immunoprecipitate the α5 subunit containing receptors we 
made use of other GABAA receptor antisera to analyze the population of receptors 
containing the α5 subunit in addition to another type of α subunit. Among α5-receptors 
containing two different types of α subunits the α1α5-combination has been found to be 
most abundant (20% of α5 receptors, Araujo et al. 1999). Therefore, we examined the 
drug binding properties of α1-GABAA receptors immunopurified from wild type and 
α5(H105R) knock-in mice. To test for α5 subunit pharmacology in the receptors 
immunoprecipitated with the α1 antiserum, the immunoprecipitates were probed for α5-
selective [3H]L655,708 binding and for [3H]Ro15-4513 binding as a control for the 
level of immunoprecipitated receptors. There was no significant difference (P > 0.5, 
Mann Whitney test) in the amount of [3H]Ro15-4513 binding sites immunoprecipitated 
with the α1 antiserum from wild type (101 ± 10 fmol/mg protein) and α5(H105R) mice 
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(99 ± 7 fmol/mg protein, Fig. 13A). However, [3H]L655,708 binding to the anti-α1 
precipitated receptors was 49 ± 6 % reduced (P < 0.02, Mann Whitney test) in 
α5(H105R) knock-in mice (1.49 ± 0.35 fmol/mg protein) as compared to wild type mice 
(2.83 ± 0.36 fmol/mg protein, Fig. 13 B).Since [3H]Ro15-4513 binding levels in the α1-
immunoprecipitate derived from α5(H105R) mice were unchanged but [3H]L655,708 
binding levels were reduced by about 50% this result indicates that in α1α5(H105R) 
receptors the α5 subunit lost its pharmacological prevalence and may have an equal 
chance to occupy the position next to the γ2 subunit as the α1 subunit.  
 
 
 
 
 
 
 
 
 
 
*
Figure 13. Reduced [3H]L655,708 binding in GABAA receptors immunoprecipitated from 
α5(H105R) mouse brain membranes indicates altered α subunit positioning in 
α1α5(H105R) receptor complexes. Crude membranes prepared from whole mouse brains (5 
mg protein/mg) were solubilized with 0.5 % deoxycholate and insoluble material removed by 
centrifugation (30 min, 100,000 x g). Aliquots of the resulting supernatant were subjected to 
immunoprecipitation with α1 antiserum. Antigen-antibody complexes were precipitated with 
Pansorbin and probed for radioligand binding. (A) [3H]Ro15-4513 binding (12 nM) was 
unchanged in α1 immunoprecipitates of both wild type (101 ± 10 fmol/mg protein) and 
α5(H105R) mice (99 ± 7 fmol/mg protein). (B) Binding of the α5-selective radioligand 
[3H]L655,708 (2 nM) to anti-α1 immunoprecipitates was 49 ± 6 % reduced in α5(H105R) mice 
(wild type 2.83 ± 0.36 fmol/mg protein, α5(H105R) mice 1.46 ± 0.35 fmol/mg protein; P > 
0.02, Mann Whitney test). Nonspecific radioligand binding was determined by including excess 
clonazepam in parallel reactions. Results are given as mean ± SD of three independent 
experiments. 
 
68 
 Results 
 
6.12 Potential involvement of α5-GABAA receptors in the modulation of NMDA 
receptor signaling cascades underlying learning and memory 
The α5-containing GABAA receptors display a unique pattern of distribution in 
mammalian brain: they are abundantly expressed in the hippocampus where they are 
located mostly at the base of the spines and on the shafts of the dendrites (Fritschy et al. 
1998, Brünig et al. 2002). This predominantly extrasynaptic location of α5-GABAA 
receptors suggests a potential modulation of NMDA receptor-mediated excitatory input 
at the spines (reviewed by Collingridge et al. 2004). The introduction of the H105R 
point mutation in the α5 subunit caused a reduction of α5-GABAA receptors in the 
hippocampus (Crestani et al. 2002) and resulted in a facilitated trace fear conditioning 
(Crestani et al. 2002), which is a hippocampus-dependent form of associative learning. 
This observation suggests that α5-GABAA receptors are contributing to the regulation 
of the dendritic excitability of hippocampal pyramidal cells and may be involved in 
controlling the NMDA receptor signaling cascade, known to play a role in learning and 
memory (Cammarota et al. 2000). To investigate whether the reduced hippocampal 
expression of α5-GABAA receptors affects downstream signaling events involved in 
learning and memory, we focused on key proteins of the NMDA receptor activated 
signaling cascade. We expected to pin down specific changes in the expression and/or 
activity of signaling proteins known to be part of NMDA receptor downstream signaling 
pathway involved in learning and memory: mitogen-activated protein kinases (p44/p42 
MAPK), calcium/calmodulin-dependent protein kinase II (CaMKII) and cAMP 
response element-binding protein (CREB) (Roberson et al. 1996, Impey et al. 1998, 
Viola et al. 2000, West et al. 2002, Thomas and Huganir 2004, Leonard et al. 1999).  
Proteins in downstream signaling pathways are often activated upon their 
phosphorylation at specific sites, which is therefore commonly used indicator of protein 
activity. In this study, hippocampal preparations from wild type and α5(H105R) knock-
in mice were analyzed by Western blotting using pan- and phosphorylation site-specific 
antibodies. Experiments using two pools of four hippocampi of each genotype indicated 
a decreased phophorylation state of CREB, MAPK p44/p42 and CaMKII, with no 
change of their protein levels in α5(H105R) mice as compared to the wild type mice 
(Fig. 14A). Other protein kinases (PKCδ, PKCε, MAPK p38, SAPK/JNK, Src) tested in 
parallel, displayed no alterations of their phophorylation states (Fig. 14 B). The 
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reduction of phosphorylated CREB in α5(H105R) mice was further confirmed in three 
additional independent experiments using distinct pools of hippocampi. Therefore, in 
α5(H105R) mice, the phosphorylation levels, i.e. the activation states, of CREB, MAPK 
p44/p42 and CaMKII were selectively reduced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Altered activation levels of downstream-signaling proteins in α5(H105R) 
knock-in mice. Hippocampal proteins from wild type and α5(H105R) knock-in mice (pools of 
four animals) were analyzed by Western blotting using site-specific antibodies for total and 
phosphorylated, i. e. activated, forms of the indicated signaling proteins. (A) Unchanged 
expression levels, but reduced phophorylation of CREB, CaMKII and MAPK p44/42 in 
α5(H105R) knock-in mice. (B) Phosphorylation and expression levels of other kinases tested 
(PKCδ, PKCε, MAPK p38, SAPK/JNK, Src) were not affected. The levels of β-actin were 
tested in parallel on the same blots and used as a control for equal protein loading. The prefix 
‘p’ indicates the phophorylated form of the respective signaling protein; wt, wild type mice; 
mut, α5(H105R) knock-in mice. 
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7 Discussion 
GABAA receptors containing the α5 subunit are located mostly extrasynaptically, at the 
base of spines and on the adjacent shafts of dendrites of hippocampal pyramidal neurons 
(Brünig et al. 2002, Fritschy and Brünig 2003). They are mediators of a persistent low-
amplitude tonic current (Caraiscos et al. 2004) and therefore expected to be involved in 
the modulation of dendritic excitability and the efficacy of excitatory inputs. The 
introduction of a point mutation (H105R) in the α5 subunit gene of mice caused a 
reduced expression of α5 subunit protein levels in the hippocampus, which resulted in 
enhanced trace fear conditioning (Crestani et al. 2002). These findings indicate that α5-
GABAA receptors play an important role in the modulation of hippocampal learning and 
memory, possibly by modulating NMDA receptor mediated responses. 
The present study aimed primarily at analyzing the consequences of the reduced levels 
of α5 subunit protein in α5(H105R) mice in respect to the assembled α5-GABAA 
receptor complex. In particular, we studied the influence of the α5(H105R) mutation on 
receptor expression, targeting, assembly and drug binding as well as on signaling 
proteins downstream of the NMDA receptor. There are two major results. 1) Receptor 
structure: The H105R mutation affects the assembly of functional, i. e. ligand binding 
α5(H105R)-GABAA receptors as well as the positioning of α subunits in α1α5-GABAA 
receptors and thereby the pharmacology of the benzodiazepine binding site. 2) Cellular 
signaling: The α5(H105R) mutation affects the activity of downstream signaling 
proteins involved in learning and memory.  
7.1 Expression levels of α5 subunits in α5(H105R) mice 
Previous studies on analogous α1(H101R), α2(H101R) and α3(H126R) knock-in mice 
demonstrated that introducing this point mutation did not affect the expression levels of 
the mutated subunit nor that of other major GABAA receptor subunits (Rudolph et al. 
1999, Löw et al. 2000). Therefore, the moderate reduction of α5 subunit protein levels 
observed by Western blotting in whole brain tissue and by immunohistochemistry in the 
hippocampus of α5(H105R) mice by Crestani et al. (2002) was rather unexpected. 
Using membrane preparations from cortex/hippocampus of α5(H105R) mice a 23 ± 2 % 
reduction of α5(H105R) subunit protein levels was found. This finding corresponded 
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well to results published on the whole brain membrane preparations (20 ± 5 %, Crestani 
et al. 2002).  
7.2 Targeting of α5-GABAA receptors 
GABAA receptor assembly occurs within the endoplasmatic reticulum and it is crucial 
for efficient inhibitory neurotransmission that correctly assembled receptors are 
transported and inserted at the appropriate synaptic or extrasynaptic sites (Kittler et al. 
2000, Moss and Smart 2001, Kittler et al. 2002). It was conceivable that the reduction 
of α5(H105R)-GABAA receptors might be a consequence of impaired receptor 
targeting. 
However, transient expression of α5β3γ2 and α5(H105R)β3γ2 receptors in HEK293 
cells resulted in similar expression levels and cell surface targeting of mutated and wild 
type receptors. The relative amount of plasma membrane-inserted α5 and α5(H105R) 
receptors amounted to about 60 % in both cases and indicated large intracellular pools 
of over-expressed subunits. The reason for similar expression levels and cell surface 
targeting of α5 and α5(H105R) receptors might be the over-expression of receptor 
subunits in the HEK293 cells, which may override subtle impairments. In addition, 
GABAA receptors are naturally expressed in neurons and thus might undergo different 
protein interactions, modifications and targeting than in HEK293 cells. Therefore, we 
analyzed targeting of α5(H105R)-GABAA receptors after transfection in neurons. To 
easily identify transfected neurons, wild type α5 subunits and α5(H105R) subunits were 
tagged with green fluorescent protein (GFP). GFP has been widely used as a tag to 
investigate the spatial and temporal organization of proteins in cells (reviewed by 
Lippincott-Schwartz and Patterson 2003). A key feature of this method is that GFP is 
genetically fused to the protein of interest and thus provides almost absolute detection 
specificity. In HEK293 cells, the GFP-tag did not affect expression or cell surface 
targeting of α5- and α5(H105R)-GABAA receptors. In neurons, both α5 and 
α5(H105R)-GFP-tagged subunits were highly expressed and targeted into proximal and 
distal neurits. This finding confirmed our previous results on comparable expression and 
targeting of α5 and α5(H105R) subunits in HEK293 cells. Therefore the H105R point 
mutation did not appear to influence the expression and targeting of α5 subunits upon 
over-expression in HEK293 cells or in cultured neurons. Thus, it is conceivable that 
subunit over-expression may compensate for minor disturbances that under normal 
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conditions would impair receptor expression, assembly or targeting. In this regard, 
results obtained using over-expressed receptors, even in neurons, should be interpreted 
with care. 
7.3 Approaches to analyzing receptor trafficking 
Methods to visualize and track GABAA receptors in living cells are central to 
characterize and understand their subcellular trafficking and targeting. Although 
fluorescent proteins have revolutionized such studies, they have shortcomings such as 
possible interference with the localization, structure or activity of the proteins to which 
they are fused (Lisenbee et al. 2003). In addition, puls-chase labeling techniques, which 
are required to analyze the trafficking and targeting of a given pool of proteins (e. g. 
trafficking of newly synthesized proteins to the cell surface) are not possible. Therefore, 
alternative approaches have been developed to label proteins in live cells (reviewed by 
Marks and Nolan 2006). 
One very promising method that is ideally suited for pulse-chase experiments was 
developed by Tsien and colleagues: the biarsenical-tetracysteine labeling technique 
(Griffin et al. 1998). This labeling method is based on the introduction of a small 
tetracysteine tag (CCPGCC) into the protein of interest, which is recognized by 
membrane-permeable red (Lumio red) or green (Lumio green) fluorescent biarsenical 
dyes (reviewed by Zhang et al. 2002). This approach has been successfully applied to 
analyze the targeting of connexin 43 in HeLa cells (Gaietta et al. 2002) and AMPA 
receptors in neurons (Ju et al. 2004). Since this method enables pulse-chase 
experiments, we aimed at applying it to assess possible differences in α5- and 
α5(H105R)-GABAA receptor trafficking and targeting in neurons. Because the 
tetracysteine tag turned out to be difficult to insert into the α5 subunit, it was engineered 
into the α1 subunit (α1TetraCys) to test the suitability of this method for GABAA 
receptors. The tetracysteine tag was inserted into the cytoplasmic loop of the α1 
subunit, since reducing conditions present in the cytoplasm are required for the covalent 
binding of the arsenic atoms of the dyes to the sulphur atoms of the tetracysteine motif. 
Although first labeling experiments with Lumio green and α1TetraCysβ2γ2 expressing 
HEK293 cells were quite promising, high background staining and toxicity of the dyes, 
particularly in neurons, prevented the application of this technique for studying GABAA 
receptor trafficking and targeting. Several attempts to reduce nonspecific staining as 
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well as toxicity of the dyes, including variation of the EDT2 concentration, labeling and 
washing times failed. A major drawback of this method seems the significant affinity of 
biarsenical dyes for isolated thiols (Stroffekova et al. 2001). Thus, presumably lengthy 
and complex washouts are required to compete out arsenic monothiol interactions. 
However in many cases even extensive washing does not eliminate background staining 
(Stroffekova et al. 2001).  
An alternative method that permits puls-chase experiments uses a recently introduced 
tag that represents the minimal binding site of the small polypeptide α-bungarotoxin 
derived from the muscle nicotinic acetylcholine receptor (Scherf et al. 2001). The 
neurotoxin α-bungarotoxin binds with high affinity and specificity to a 13 amino acid 
long sequence (WRYYESSLEPYPD), which can be introduced into any protein of 
interest to serve as a tag. α-Bungarotoxin is available in a fluorescent, biotinylated and 
radioactive form and has been successfully applied in a variety of assays including 
pulse-chase experiments (Scherf et al. 2001, Katchalski-Katzir et al. 2003). Since α-
bungarotoxin is not able to permeate the plasma membrane, we placed the minimal 
binding sequence for α-bungarotoxin (btx) into the extracellular domain of the α5 
subunit (α5btx). This strategy enables selective labeling of cell-surface receptors and 
analysis of membrane insertion and internalization of the receptor. The labeling 
procedure using AlexaFlour488-α-bungarotoxin was first established on HEK293 cells 
expressing the α5btxβ3γ2 subunit combination and yielded a staining pattern that 
perfectly colocalized with α5 and β3 antibody signals with virtually no background 
staining. This result is in accordance with similar studies on AMPA receptors (Sekine-
Aizawa and Huganir 2004) and the β3 subunit of GABAA receptors (Bogdanov et al. 
2006). Since we aimed at monitoring α5 and α5(H105R) receptors in neurons, we 
adapted this labeling strategy for cultured neurons transfected with the α5btx construct. 
One potential problem using neurons with this tagging method is the presence of 
endogenous α7 nicotinic acetylcholine receptors that binds α-bungarotoxin as well. 
Therefore, we blocked endogenous α-bungarotoxin binding sites with the antagonist 
tubocurarine as recommended by Sekine-Aizawa and Huganir (2004) prior to labeling 
of α5(btx)-GABAA receptors with AlexaFlour488-α-bungarotoxin. Unfortunately, 
nontransfected and transfected neurons unexpectedly showed significant background 
levels when labeled in this way with AlexaFlour488-α-bungarotoxin. This outcome 
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illustrated that the difficulty of blocking endogenous α-bungarotoxin binding sites in 
neurons is a major shortcoming of this method. Future experiments using higher 
concentrations of tubocurarine, or alternatively unlabeled α-bungarotoxin (Bogdanov et 
al. 2006), might, at least partially, reduce the background staining. For easier 
identification of transfected neurons it might be helpful to introduce an additional tag 
into the α5btx construct. However, our goal was to minimize number and size of tags to 
be introduced, because with every tag the risk to affect the physiological function and 
properties of the receptor complexes rises. This method clearly has the potential to trace 
important aspects in GABAA receptor trafficking.  
7.4 The H105R mutation affects assembly of α5-GABAA receptors 
Since the H105R mutation did not appreciably affect cell surface expression and 
targeting of α5 receptors into neurites, we hypothesized that the assembly of α5-
GABAA receptors might be disturbed. This is a very likely hypothesis since it has been 
shown that amino acids involved in mediating inter-subunit contacts are in close 
proximity to histidine 105. To achieve the correct order of subunits around the pore, 
each subunit must be able to recognize and to interact with its neighbors via specific 
high-affinity contact sites. For some of the GABAA receptor subunits amino acid 
sequences that are important for the correct assembly of the receptor complex have been 
identified (α1: Taylor et al. 2000, Klausberger et al. 2000, Sarto et al. 2002b, Sarto-
Jackson et al. 2006; β2/3: Taylor et al. 1999, Sarto et al. 2002b; γ2: Sarto et al. 2002b, 
Sarto-Jackson et al. 2006; γ3: Sarto et al. 2002a). In the case of association of 
α1 with γ2 subunits an important contact site is located proximal to the benzodiazepine 
binding site (Boilleau et al. 1999, Teissere and Czajkowski 2001). Most importantly, 
Sarto-Jackson et al. (2006) showed that one of the key amino acids for the assembly of 
the α1 subunit with β3 and γ2 subunits is alanine 108 (A108) in the α1 subunit. Thus, it 
is reasonable to assume that mutation of amino acids in close proximity to A108, like 
the H105R mutation in the α5 subunit, might affect assembly of the receptor complex.  
For determination of the level of assembled GABAA receptors we made use of the fact 
that only fully assembled GABAA receptors containing a α, β and γ2 subunit bind 
benzodiazepine site ligands. Receptor autoradiography using [3H]Ro15-4513, which 
binds to all GABAA receptor subtypes containing the γ2 subunit, revealed a 7 ± 0.5 % 
reduction of [3H]Ro15-4513 binding in the hippocampus of α5(H105R) mice. Since 
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about 20% of GABAA receptors in the hippocampus contain the α5 subunit, i. e. display 
α5-GABAA receptor pharmacology (Sur et al. 1998), this level of reduction in 
[3H]Ro15-4513 binding indicates a loss of about 30-40% of α5-GABAA receptors in the 
hippocampus of α5(H105R) mice. Since the level of α5 subunit protein was only 
reduced by about 20%, this finding indeed suggests that the H105R mutation might 
affect assembly of α5-GABAA receptors. In agreement with this observation, receptor 
autoradiography using the α5-selective ligand [3H]L655,708 revealed a 47 ± 5 % 
reduction of binding in the whole hippocampus. In addition, the same level of reduction 
was observed in all other brain areas expressing α5-GABAA receptors, e. g. olfactory 
bulb (39 ± 4 %), superior colliculus (43 ± 0.4 %) and motor cortex (53 ± 6 %). Thus, the 
decrease of α5-GABAA receptors is not limited to the hippocampus as indicated by the 
published immunohistochemical data (Crestani et al. 2002), but concerns the entire α5-
GABAA receptor population. Saturation binding experiments verified that the reduction 
in high affinity [3H]L655,708 binding was not caused by a decreased affinity in 
response to the H105R mutation. The analysis demonstrated virtually identical KD 
values for [3H]L655,708 in brain membrane preparations from wild type and 
α5(H105R) mice but a strongly reduced number of binding sites (76 %) in α5(H105R) 
mice. These findings suggest the impairment of a fundamental process responsible for 
the receptor formation. 
The discrepancy in levels of ligand binding to α5-GABAA receptors (76 % reduction) 
and expression levels of α5 subunit protein (23 % reduction) in α5(H105R) mice might 
be due to an inefficient assembly of the receptor complex, resulting in considerable 
amounts of unassembled α5 subunits. This hypothesis was tested by sucrose gradient 
centrifugation to separate high molecular assembled receptor complexes from 
unassembled low molecular size subunits. In brain extracts from α5(H105R) mice, the 
α1, α5, β2/3 and γ2 subunits were found exclusively in the high molecular fractions and 
thus indicated the presence of assembled α5(H105R)-GABAA receptors. However, 
[3H]L655,708 binding was about 60% lower in the high molecular fractions derived 
from α5(H105R) mice than in fractions derived from control mice. This correlated well 
to the 76 % reduction of α5 receptor binding sites determined in the saturation binding 
experiments. Thus, although the binding of the α5-selective ligand [3H]L655,708 was 
strongly reduced, the α5(H105R) subunits were found to assemble into macromolecular 
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complexes. This result suggests that a large proportion of α5-GABAA receptors 
assemble into severely impaired receptor complexes that are non-functional and do not 
bind ligands and are most likely destined for degradation. Degradation of misassembled 
receptor complexes is most likely mediated via the endoplasmatic reticulum-associated 
protein degradation pathway, which involves ubiquitination and translocation of the 
protein complexes from the ER into the cytoplasm for degradation by proteasomes 
(reviewed by Hirsch et al. 2004). This multi-step process may be slow and would lead 
to the intracellular accumulation of misassembled receptors, which would explain the 
moderately reduced expression levels of α5(H105R) subunit protein but a strong 
reduction of α5-selective ligand binding.  
7.5 The H105R mutation affects positioning of α5 subunits within α1α5-
GABAA receptors 
It is interesting to note that immunodepletion experiments indicated that the His to Arg 
mutation solely rendered those GABAA receptors insensitive to diazepam binding, 
which contain two mutated α subunits in the receptor complex. Receptors containing 
one mutated and one non-mutated distinct type of α subunit, e. g. α1(H101R)α2-
receptors, remained sensitive to diazepam binding (Benke et al. 2004). Mechanistically, 
the data implied that the non-mutated α subunit preferentially assembles with the γ2 
subunit and thus conveys the respective benzodiazepine site binding properties to the 
receptor complex. In line with this finding, recent approaches linking the subunits 
covalently together, to assess the consequences of the subunit position within the 
receptor complex, demonstrated that only the α subunit next to the γ2 subunit 
determined the benzodiazepine binding characteristics of the receptor complex (Minier 
et al. 2004). Therefore, it might well be that the H105R mutation affects the positioning 
of the α5 subunit within receptors containing two different types of α subunits. 
Concerning α5-GABAA receptors, it has been found that a considerable proportion 
contain two distinct types of α subunits. In the α1-GABAA receptor population, which 
is the major GABAA receptor subtype (about 60 % of diazepam-sensitive GABAA 
receptors, Benke et al. 1991a, Benke et al. 1991b, Mertens et al. 1993), 9% of the 
receptors contain in addition to the α1 subunit the α5 subunit (Araujo et al. 1999). 
Furthermore, α2α5-GABAA receptors represent about 20 % of the α2-GABAA receptor 
population in the rat hippocampus (del Rio et al. 2001). Therefore, the fraction of 
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receptors containing in addition to the α5 subunit another type of α subunit may 
constitute about 50% of the pool of α5-GABAA receptors in the hippocampus. 
Interestingly, in both the α1α5-receptors and α2α5-receptors the α5 subunit was found 
to be pharmacologically dominant over the α1 subunit and α2 subunit, respectively, and 
solely displayed α5 pharmacology (Araujo et al. 1999, del Rio et al. 2001). Thus, in α5-
GABAA receptors containing a second type of α subunit, e. g. α1 or α2, the α5 subunit 
would always be located next to the γ2 subunit. 
To test the hypothesis that the H105R mutation might change the position of the α5 
subunit, we estimated in a first set of experiments the relative abundance of the distinct 
zolpidem binding sites in wild type and mutant mice corresponding to the α1 (high 
affinity), α2/α3 (moderate affinity) and α5-GABAA receptor populations (low affinity) 
using zolpidem displacement of [3H]Ro15-4513 binding. The rational behind this 
experimental approach was that if the H105R mutation decreases the affinity of the α5 
subunit to associate with the γ2 subunit in a way that the second, non-mutated α subunit 
(e.g. α1) becomes the preferred partner of the γ2 subunit then the zolpidem binding 
properties of this receptor complex will be shifted from low affinity to high affinity. 
Thus, we expected to observe a shift in the relative abundance of low affinity zolpidem 
sites (α5) to high affinity zolpidem sites (α1). Indeed, in all individual experiments, we 
detected in preparations from α5(H105R) mice a slight increase in the relative 
abundance of high affinity zolpidem sites corresponding to α1-GABAA receptors and a 
concomitant decrease in low affinity zolpidem sites corresponding to α5-GABAA 
receptors. The decrease in low affinity zolpidem binding sites is, however, not only 
caused by a shift in the positioning of the α5 subunit in α1α5 receptor complexes but 
also due to the general down regulation of α5-GABAA receptors in the α5(H105R) 
mice. In addition, low expression levels of α4-GABAA receptors in hippocampus/cortex 
contribute to low affinity zolpidem sites (Benke et al. 1997) and is further 
compromising a quantitative interpretation of the abundance of low affinity zolpidem 
binding sites corresponding to α5-GABAA receptors. Nevertheless, the consistently 
observed small increase of high affinity zolpidem binding sites in α5(H105R) mice 
suggests that the H105R mutation may have influenced the positioning of the α5 
subunit in receptor complexes containing in addition a α1 subunit. 
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Immunoprecipitation experiments provided further evidence that the positioning of the 
α5 subunit in α1α5-GABAA receptor might be changed in α5(H105R) mice. Using α1 
subunit-selective antibodies the entire population of α1-GABAA receptors was isolated 
and the abundance α1α5-receptors was determined by high-affinity [3H]L655,708 
binding. The abundance of the total pool of α1 subunit containing GABAA receptors 
was similar in wild type and α5(H105R) mice as judged by [3H]Ro15-4513 binding. 
However, high affinity [3H]L655,708 binding, corresponding to α5 subunit properties, 
was reduced to about 50 % in α5(H105R) knock-in mice. Thus, this finding indicates 
that the α5(H105R) subunit was in about 50 % of cases pharmacologically inactive 
when assembled together with the α1 subunit in the receptor complex. Since in wild 
type animals the α5 subunit is pharmacologically dominant over the α1 subunit and 
therefore favorably arranged next to the γ2 subunit (Araujo et al. 1999), this finding 
indicates that the H105R mutation reduces the affinity of the α5 subunit to assemble 
with the γ2 subunit to a degree that the α1 subunit can take the position next to the γ2 
subunit with the same probability as the α5(H105R) subunit.  
7.6 Regulation by α5-GABAA receptors of downstream signaling proteins 
involved in hippocampal learning and memory 
Genetic and pharmacological studies on α5-GABAA receptors in rodents indicated this 
subtype as one of the molecular substrates in hippocampal-dependent learning and 
memory processes (Collinson et al. 2002, Crestani et al. 2002, Chambers et al. 2003). 
The partial down regulation of α5-GABAA receptors in α5(H105R) mice resulted in an 
improved performance in the trace-fear conditioning paradigm (Crestani et al. 2002). It 
has been shown that memory consolidation on the cellular level is initiated by the 
activation of NMDA receptors, followed by changes in the level of second messengers, 
enhanced activity of protein kinases and transcription factors leading to de novo protein 
synthesis (Bozon et al. 2003, reviewed by Abel and Lattal 2001, reviewed by Nakazawa 
et al. 2004). Since the behavioral consequences of a reduced level of α5-GABAA 
receptors oppose those of a deficit of NMDA receptors (Tang et al. 1999, Shimizu et al. 
2000), these two receptor systems appear to play a complementary role in controlling 
the signal transduction at hippocampal principal cells. Because α5-GABAA receptors 
are primarily found in extrasynaptic regions of spines and dendritic shafts of pyramidal 
79 
Discussion  
neurons (Crestani et al. 2002, Brünig et al. 2002), they are in a favored position to 
modulate excitatory input arising at the spines via NMDA receptors. If this is the case, 
activity of α5-GABAA receptors might be reflected in the modulation of the activity of 
signaling proteins involved in learning and memory activated by NMDA receptors. 
It has been reported that in hippocampal principal cells α5-GABAA receptors are 
mediating tonic inhibition (Caraiscos et al. 2004, Scimemi et al. 2005, Prenosil et al. 
2006) that is thought to play a critical role in regulation of network excitability 
(Semyanov et al. 2003) and information processing (Mitchell and Silver 2003). 
Although deletion or reduction of α5-GABAA receptors, respectively, improves certain 
aspects of cognitive performance (Collinson et al. 2002, Crestani et al. 2002) and 
suggests a negative influence of α5-GABAA receptors on cognition, they may be very 
important protecting neurons from excessive excitation by mediating tonic inhibition. 
Scimemi and colleagues (2005) showed that α5-GABAA receptors contribute to tonic 
inhibition virtually only under conditions of increased GABA concentrations. At lower 
GABA levels tonic inhibition appears to be mediated by δ-GABAA receptors. The δ-
GABAA receptors are as well expressed extrasynaptically and display an exceptionally 
high affinity for GABA, which enables them to detect submicromolar concentrations of 
GABA (reviewed by Farrant and Nusser 2005). On the contrary, α5-GABAA receptors 
are activated by higher GABA concentrations, which are generated as a result of 
enhanced physiological activities (Bianchi et al. 2003) and pathological states 
(Smolders et al. 2004). Thus, α5-GABAA receptors come into play during periods of 
activity, which perfectly correlates with the activity of NMDA receptors and therefore 
are very well suited to modulate their excitatory input. 
Since NMDA receptors control the CaMKII and MAPK pathways, which both converge 
at the level of the transcription factor CREB (Wu et al. 2001, reviewed by West et al. 
2002), we analyzed the activation states of the key proteins of these signaling cascades 
in hippocampi of α5(H105R) mice as compared to wild type mice. Interestingly, we 
detected reduced phosphorylation levels, i. e. activation states, selectively for CaMKII, 
p44/42 MAPK and CREB in the hippocampus of α5(H105R) mice with no change in 
their protein levels. This effect was specific since the activation states of several other 
protein kinases tested in parallel remained unchanged. At present, it is not clear why the 
activity of CaMKII, p44/42 MAPK and CREB is reduced in α5(H105R) mice. A 
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reduced expression of functional α5-GABAA receptors in the hippocampus is expected 
to result in a reduced inhibitory tone at spines of hippocampal pyramidal neurons and 
thus to an increase in NMDA receptor activity. An increased activity of synaptic 
NMDA receptors would consequently result in an enhanced activity of downstream 
signaling proteins. However it may well be that the activity of CaMKII, p44/42 MAPK 
and CREB is down-regulated to compensate for a chronically enhanced NMDA 
receptor response. 
Activated CREB, i. e. CREB phosphorylated at Ser133 (pCREB), has been shown to be 
time-dependently increased in inhibitory avoidance training and spatial novelty tests 
(Impey et al. 1998, Taubenfeld et al. 1999, Cammarota et al. 2000, Viola et al. 2000, 
Vianna et al. 2000). In future experiments, it would be interesting to analyze how 
CREB activity is regulated in α5(H105) mice subjected to these tests. 
 
Conclusions  
8 Conclusions 
The data of the current study indicate that the H105R mutation in the α5 subunit 
severely affects the assembly of functional, i. e. ligand binding α5-GABAA receptors. A 
large fraction (~50%) of mutated α5-GABAA receptors form high molecular complexes 
similar to non-mutated α5-GABAA receptors but do not bind ligands of the 
benzodiazepine binding site. They most likely represent misassembled, non-functional 
receptors to be degraded. Since degradation by the endoplasmatic reticulum-associated 
protein degradation pathway is a relatively slow process (reviewed by Hirsch et al. 
2004) this may be reflected by the moderately reduced (~20%) expression levels of 
α5(H105R) subunit protein. 
In addition, α5(H105R) subunits that successfully assemble into functional receptors 
appear to display a reduced affinity to associate with the γ2 subunit. This leads to a 
further reduction of α5-specific drug binding properties in receptors containing in 
addition to the mutated α5 subunit the α1 subunit (α1α5-GABAA receptors). 
The strong reduction of functional α5-GABAA receptors in α5(H105R) mice is 
expected to result in an reduced inhibitory tone at hippocampal pyramidal spines, 
leading to enhanced NMDA receptor activity. The reduced activity of downstream 
signaling proteins (CaMKII, MAPK 44/42 and CREB) observed in α5(H105R) mice 
might therefore reflect an adaptive response to compensate for the enhanced NMDA 
receptor signaling.  
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10 Abbreviations 
AMPA   α-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid 
BES buffer  N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid buffer 
BIG2   brefeldin A-inhibited GDP/GTP exchange factor 2 
CaMKII  calmodulin-dependent protein kinase II 
CREB protein  cAMP responsive element binding protein 
Cy3   Indocarbocyanine (absorption 550 nm, emission 570 nm) 
Cy5   Indocarbocyanine (absorption 650 nm, emission 670 nm) 
DIV   days in vitro 
DMEM  Dulbecco’s modified eagle medium 
DMSO   dimethyl sulfoxide 
E   embryonic day 
EDT2   1,2-ethanedithiol 
EDTA   ethylenediamine tetraacetic acid 
ELISA   enzyme-linked immunosorbent assay 
ER   endoplasmatic reticulum 
GABAA receptor γ-aminobutyric acid type A receptor 
GABARAP  GABAA receptor associated protein 
GFP   green fluorescent protein 
GODZ   Golgi-specific zinc finger protein 
GRIF   GABAA receptor interacting factor 
GRIP   glutamate receptor interacting protein 
HAP1   Huntington-associated protein 1 
HEK293 cells  human embryonic kidney cells 
HeLa cells  immortalized human epithelial cells from cervical carcinoma 
HRP   horseradish peroxydase 
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MAPK   mitogen-activated protein kinase 
MEM   minimum essential medium 
NGS   normal goat serum 
NMDA  N-methyl-D-aspartate 
NSF   N-ethylmaleimide-sensitive factor 
p   phospho- 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
PFA   paraformaldehyde 
PKC   protein kinase C 
Plic-1   proteins that link integrin associated protein to the cytoskeleton 
PRIP   phospholipase C-related inactive proteins 
SAPK/JNK  stress-activated protein kinase/c-Jun NH2 terminal kinase 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Src   proto-oncogenic tyrosine kinase 
TBST   tris buffered saline tween-20 
TM   transmembrane 
TMB   tetramethylbenzidine 
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